FLUKE CORP
10-K, 1995-07-27
INSTRUMENTS FOR MEAS & TESTING OF ELECTRICITY & ELEC SIGNALS
Previous: FLUKE CORP, DEF 14A, 1995-07-27
Next: FOOD LION INC, 10-Q, 1995-07-27




                     SECURITIES AND EXCHANGE COMMISSION
                          Washington, D.C.    20549

                              FORM 10-K

Annual Report Pursuant to Section 13 or 15(d) of the Securities 
Exchange Act of 1934

For the year ended April 28, 1995.

Commission file no. 1-5590

Fluke Corporation
(Exact name of registrant as specified in its charter)

Washington
(State of incorporation or organization)

91 - 0606624
(I.R.S. Employer Identification No.)

6920 Seaway Boulevard Everett, Washington  98203
(Address of principal executive offices)

(206)  347 - 6100
(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class            Name of each exchange on which 
registered

Common Stock, par value $.25           New York Stock Exchange

Securities registered pursuant to Section 12(g) of the Act:

Title of each class

Common Stock Purchase Rights

Indicate by check mark whether the Registrant (1) has filed all 
reports required to be filed by Section 13 or 15 (d) of the 
Securities Exchange Act of 1934 during the preceding 12 months (or 
for such shorter period that the registrant was required to file such 
reports), and (2) has been subject to the filing requirements for the 
past 90 days.

Yes     X          No

Indicate by check mark if disclosure of delinquent filers pursuant to 
Item 405 of Regulation S-K is not contained herein, and will not be 
contained, to the best of registrant's knowledge, in definitive proxy 
or information statements incorporated by reference in Part III of 
this Form 10-K or any amendment to this Form 10-K.  [   ]

As of July 14, 1995, there were 7,981,426 shares of $0.25 par value 
common stock outstanding and the aggregate market value of the common 
shares (based upon the closing price of the shares on the New York 
Stock Exchange) held by nonaffiliates was approximately $222 million.

Documents Incorporated By Reference

The following documents are incorporated by reference in the listed 
parts of this Annual Report on Form 10-K:

Document                                                 Part of 10-K

1.  Annual Report to Stockholders for the year ended
    April 28, 1995 
   (only the portions listed in this report)           Parts I and II

2.  Proxy Statement dated July 25, 1995 
   (only the portions listed in this report)                 Part III


PART I

ITEM 1 - BUSINESS

Fluke Corporation (the Company), was founded in 1948 and was 
incorporated under the laws of the State of Washington on October 7, 
1953.  In August, 1993, the Company changed its name from John Fluke 
Mfg. Co., Inc. to Fluke Corporation. The Company is engaged in the 
design, manufacture and marketing of compact, professional electronic 
test tools.  The Company's principal products are portable 
instruments that measure the magnitude of voltage, current, power 
quality, frequency, temperature, pressure and other key functional 
parameters of electronic equipment.

The Company believes that there are a number of key trends occurring 
throughout the world that are driving the need for portable 
electronic test tools: increasing device complexity, growing 
electronic content in existing and new applications, decentralization 
of electronic systems and increasing reliance on mission critical 
electronic systems.  In addition, the increasing need for companies 
to improve quality, document compliance with regulatory or industrial 
standards, and maintain a safe working environment has further 
increased the need for electronic test tools.  These general trends 
have greatly increased the need for trained technicians to be able to 
install, maintain and diagnose electrical systems at widespread 
locations.  These trained technicians are responsible for enhancing 
the up-time of electrical systems and have a new set of needs in the 
tools they use to perform their jobs.  These tools need to be 
portable, precise, rugged and easy to use.  These technicians use 
these tools to measure electrical parameters across a wide variety of 
fields and industries.  

Fluke's targeted end-users are service, installation and maintenance 
professionals who use the Company's tools to identify, diagnose and 
solve electrical problems. Fluke's portable digital multimeters, 
ScopeMeter (Registered Trademark) test tools and calibration 
equipment, which have substantial and leading market shares, are used 
for field testing and verification of a broad range of electronic 
equipment.  The Company has leveraged its competencies and market 
presence by offering new products for emerging applications.  These 
include products that address local area networks (LANs), process 
control, data acquisition (temperature control, counting and other 
unattended data gathering), power analyzers and automotive 
electronics.  The Company also manufactures and markets traditional 
bench test and measurement instruments, such as bench oscilloscopes.

PRODUCTS AND SERVICES

PRODUCTS

The Company is in a single line of business, the manufacturing and 
selling of electronic test tools.  Although the products vary in 
capability, sophistication, use, size and price, they all 
fundamentally test and measure electrical parameters such as voltage, 
current, resistance, etc.
As of May 1995, the Company offered over 200 product models with over 
1,300 options and accessories.  These products are divided into two 
product classes: handheld service tools and benchtop test 
instruments.
Handheld service tools are typically used in field service 
applications by technicians to install and troubleshoot electronic 
and electrical equipment.  Most of these tools are sold through 
indirect distribution channels.  Representative products include 
handheld digital multimeters, ScopeMeter test tools, and LAN testers.
Benchtop test instruments are used primarily by engineers and are 
most often sold through Fluke direct sales channels.  Products 
include bench oscilloscopes, calibrators, data acquisition systems, 
and generators.

Handheld service tools were approimately 55 percent of the business in 1995, 
49 percent in 1994, 50 percent in 1993 and 48 percent in 1992.  Benchtop 
test instruments were approximately 36 percent of the business in 1995, 42 
percent in 1994, 41 percent in 1993 and 43 percent in 1992.  The remaining 
business consisted of service and parts for products that the Company sells.

NEW PRODUCTS

Fluke Corporation introduced the following major products in fiscal 1995.

ScopeMeter Series II.  Four new models were introduced.  ScopeMeter 
(registered trademark) test tools combine the functions of an oscilloscope 
with that of a digital multimeter in a handheld instrument.  

701/702 Documenting Process Calibrators.  These are the first handheld, 
multifunction calibrators with full documentation capabilities designed 
specifically for the calibration, troubleshooting and maintenance of process 
instrumentation. 

5500A Multi-Product Calibrator.  This is a new class of multifunction 
calibrator designed for today's increasingly broad calibration needs.  It is 
used to calibrate a wide range of dc/low frequency instrumentation.

860 Series Graphical(Trademark) Multimeters.  These test tools combine 
digital multimeter capabilities with analog, digital and graphical displays.  
The 860 Series is a family of three instruments. 

DSP-100 LAN CableMeter(Trademark).  This handheld test tool is designed to 
meet the soon to be announced standards for testing installed Category 5, 
ISO and IEC local area networks (LAN) cabling to 100 MHz.  The DSP-100 uses 
a patented digital signal processing (DSP) technology.

NetDAQ(Trademark).  These networked data acquisition units are portable, 20-
measurement channel front-end data acquisition instruments that connect 
directly to a PC, or can transmit data via an Ethernet network.

PM3380A CombiScope(Trademark).  This is a full function low-cost two channel 
oscilloscope designed for the engineer.

PM3394A CombiScope(Trademark). This is another oscilloscope in the 
CombiScope family of instruments that combine digital storage and an analog 
oscilloscope.

PM 6685R Rubidium Timebase Frequency Counter.  This frequency counter has a 
new atomic reference that makes it the most accurate frequency counter on 
the market in its price range. 

SALES AND DISTRIBUTION

The Company currently markets its products in more than 80 countries through 
both indirect and direct sales channels.  The Company's indirect sales 
channels, those in which the Company does not invoice the end-user, include 
industrial distributors, catalog houses, automotive warehouses and 
electrical wholesalers.  The Company's direct sales channels include both 
the Company's internal sales force, which the Company has in Western Europe, 
Canada, Japan and Singapore and independent manufacturer's representatives 
located in the U.S. and many other international markets.  Direct and 
indirect sales channels will typically serve different customers in the same 
geographic areas.

The Company generally uses indirect distribution for its hand-held service 
tools.  The Company has found that the end-users purchasing these tools 
often do not require ongoing product support or specific instructions on 
tool applications.  This distribution channel more effectively serves the 
customers purchasing needs for these products.

The Company uses its direct sales channels primarily for its benchtop test 
instruments.  These products are generally more technically complex products 
where the customer may require a greater amount of direct contact to close 
or support a sale.  Direct sales channels are also used effectively in 1) 
those markets in which a substantial knowledge of the end-user's business is 
required, such as among potential customers for the LANMeter, and 2) in 
those geographic areas which do not have fully developed indirect 
distribution channels or where the customer still expects to purchase hand-
held service tools through a direct sales force.  In May 1995, the Company 
shifted all of its direct sales responsibilities in the U.S. from an 
internal sales force to fifteen manufacturer's representatives.

The Company's marketing effort consists principally of advertising in trade 
publications, appearing at trade shows, and to a lesser extent, utilizing 
direct mail campaigns.



SUPPLIERS

The Company generally uses standard parts and assemblies available from a 
number of suppliers.  However, some components are only available from a 
single source. The Company has not experienced significant problems in 
obtaining sole-source components but typically carries extra inventory of 
any critical sole-sourced components.  Fluke works closely as partners with 
its suppliers in an effort to assure a continuity of supply even during 
difficult allocation times.  The Company is not aware of any facts which 
would result in a reduction, interruption or termination in the supply of 
its sole-sourced components.

PATENTS AND TRADEMARKS

The Company regards elements of its products as proprietary and relies 
primarily on a combination of patent, copyright, trademark and trade secret 
laws, confidentiality procedures, license agreements and other intellectual 
property protection methods to protect its proprietary technology.  The 
Company holds or has pending United States and foreign patents to protect 
product designs, processes and techniques for the duration of their value to 
the Company.  No significant patents have been formally upheld in court and 
no representation is made as to the validity or the degree of protection 
afforded by any patent.  While the Company considers its existing and 
pending patents to be important and expects to defend and to continue to 
apply for patents with respect to any significant developments it regards as 
patentable, it does not consider its business as dependent to any material 
extent upon any one or more of such patents, nor would its present business 
be materially adversely affected if any of the patents were held invalid.The 
Company also owns trademarks, copyrights and proprietary information, which 
are considered by the Company to have significant value.

SEASONAL TRENDS AND WORKING CAPITAL REQUIREMENTS

While the Company is subject to minor seasonality effects associated with 
conducting business in various regions of the world, the impact of these 
seasonal trends is immaterial to the Company as a whole.  The Company does 
not have any extraordinary working capital requirements.

CUSTOMERS

The Company's customers are generally involved in the installation, service, 
repair, or calibration of electronic or electrical equipment. They are also 
involved in research and development activities.

No one customer accounted for more than five percent of the Company's sales 
in fiscal year 1995.

BACKLOG

The Company's backlog of unfilled orders amounted to $45.1 million as of 
April 28, 1995, and $37.0 million as of April 29, 1994.  The Company expects 
to satisfy nearly all such unfilled orders in fiscal 1996.  The backlog 
consists of many different customer orders with no one customer being a 
material component.



COMPETITION

The market for electronic test tools is widely fragmented, consisting of a 
large number of companies, generally focused on one or a few products or 
markets.  Fluke maintains a broad product offering targeted to many 
different applications and markets.  The Company believes that its products 
compete principally on the basis of performance, service and warranty, and 
to a lesser extent, price.  While there are numerous firms engaged in the 
production of electronic test tools, no single company competes with the 
Company across a substantial portion of its markets.  It does, however, have 
competitors that are substantially larger than the Company and have greater 
financial resources.

RESEARCH AND DEVELOPMENT

The Company's research activities are directed toward the development of new 
products that will complement and expand the present product line, and 
toward the creation of new manufacturing techniques.  Research and 
development expense was $37.7 million for the year ended April 28, 1995 
which was 10.0 percent of the Company's fiscal 1995 revenues.  Research and 
development expense was $34.9 million for the year ended April 29, 1994, 
$13.7 million for the seven months ended ended April 30, 1993 and $22.5 
million for the year ended September 1992 which were 9.8, 10.3 and 8.3 
percent of the Company's total revenues, respectively.  No research 
contracts are obtained from customers, nor does the Company conduct any 
research work under government development contracts.

ENVIRONMENTAL CONTROLS

The Company does not anticipate any material effects upon its capital 
expenditures, earnings or competitive position as a result of compliance 
with federal, state and local provisions regulating the discharge of 
materials into the environment or otherwise relating to the protection of 
the environment.

EMPLOYEES

The Company had 2,516 full-time employees as of April 28, 1995.

FOREIGN OPERATIONS AND EXPORT SALES

Information related to foreign operations and export sales is incorporated 
herein by reference to Note 10 of the Consolidated Financial Statements on 
page 52 of the Company's 1995 Annual Report to Stockholders, a copy of which 
is filed as Exhibit 13 to this report.

The Company has significant revenues from outside of the United States which 
increase the complexity and risk to the Company.  These risks include 
increased exposure to the risk of foreign currency fluctuations and the 
potential economic and political impacts from doing business in foreign 
countries including changes in labor and tax laws, import and export 
controls and changes in governmental policies.

EXECUTIVE OFFICERS OF THE REGISTRANT

The Executive Officers, who serve at the pleasure of the Board of Directors 
of the Company, as of June 23, 1995, are as follows:



WILLIAM G. PARZYBOK, JR.

Mr. Parzybok, age 53, has been Chairman of the Board, Chief Executive 
Officer and a Director of the Company since 1991.  He previously had been 
employed for 22 years by the Hewlett-Packard Company where his most recent 
position was Vice President and General Manager of Engineering Applications 
Group from 1988 to 1991.  Mr. Parzybok serves on the Executive Committee of 
the Board.  He is also a Director of  PENWEST, Ltd.

GEORGE M. WINN

Mr. Winn, age 51, has been President, Chief Operating Officer and a Director 
of the Company since 1982.  He previously served as Chief Executive Officer 
of the Company from 1987 to 1991.  Mr. Winn serves on the Executive 
Committee of the Board.  He is also a Director of Heart Technology, Inc.

RICHARD W. VAN SAUN

Mr. Van Saun, age 57, has been a Senior Vice President of the Company and 
General Manager of the Service Tools Division since 1994.  He previously 
served as Senior Vice President and Group Manager of the Diagnostic Tools 
Division from 1992 to 1994 and as Vice President and Group Manager of the 
Service Equipment Group from 1986 to 1992.

RONALD R. WAMBOLT

Mr. Wambolt, age 60, has been a Senior Vice President of the Company and 
Director of Worldwide Sales and Service since 1991.  He previously served as 
Senior Vice President and Director of Worldwide Sales from 1987 to 1991.

WILLIAM R. HOFFMAN

Mr. Hoffman, age 59, is a Vice President of the Company and Manager of 
Corporate Services. He is also General Manager of Calibration for the 
Verification Tools Division.  He previously served as Vice President of 
Marketing Services and the Philips T&M Group from 1991 to 1992, and as Vice 
President of the Company and Group Manager of the Philips T&M Group from 
1987 to 1991.

DAVID E. KATRI

Mr. Katri, age 45, has been a Vice President of the Company and General 
Manager of the Verification Tools Division since 1992.  He previously served 
as Vice President of the Company and Group Manager of the Manufacturing/R&D 
Group from 1991 to 1992, and as Group Manager of the Manufacturing/R&D Group 
from 1988 to 1990.

DOUGLAS G. MCKNIGHT

Mr. McKnight, age 46, has served as Vice President, General Counsel of the 
Company since 1986 and as Corporate Secretary since 1983.

PATRICK J. O'HARA

Mr. O'Hara, age 42, has been Vice President, Human Resources and Facilities 
Manager of the Company since September, 1994.   He previously served as 
Deputy Director of Human Resources at the Los Alamos National Laboratory 
from 1993 to 1994, and prior to that, as Site Human Resources Manager of the 
T.J. Watson Research Center of IBM Corporation from 1990 to 1993.

BARRY L. ROWAN

Mr. Rowan, age 38, has been Vice President and Chief Financial Officer of 
the Company since 1992.   He previously had been employed by Comlinear 
Corporation where he served as President from 1989 to 1991.

JOHN R. SMITH

Mr. Smith, age 54, has been Vice President, Treasurer of the Company since 
1987.


ITEM 2 - PROPERTIES

The Company owns approximately 162 acres of real estate near Everett, 
Washington, the site of its corporate headquarters and U.S. manufacturing, 
warehousing and distribution facilities.  These facilities are housed in six 
separate facilities consisting of approximately 480,000 square feet, 200,000 
square feet and four smaller facilities totaling 77,800 square feet.  The 
Company also owns a 25,000 square foot service facility situated on 1.5 
acres in Paramus, New Jersey and a 27,000 square foot service facility 
situated on 4.8 acres in Palatine, Illinois.  All facilities owned by the 
Company are insured at their estimated replacement cost.

The Company leases three facilities in The Netherlands, consisting of a 
138,400 square foot engineering and manufacturing facility located at 
Almelo, a 17,600 square foot European headquarters and a 10,700 square foot 
service facility both located at Eindhoven.  These properties could be 
duplicated, if necessary, with some disruption to operations.  The Company 
has approximately 189,300 square feet of additional leased facilities 
throughout the world which are utilized for sales and service.  The Company 
believes that its existing facilities are in good condition and are suitable 
and adequate for its business.

ITEM 3 - LEGAL PROCEEDINGS

Not applicable.

ITEM 4 - SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

Not applicable.

PART II

ITEM 5 - MARKET FOR THE REGISTRANT'S COMMON EQUITY AND RELATED STOCKHOLDER
         MATTERS

The information required by this Item is incorporated herein by reference to 
Stock Price Information on page 58 of the Company's 1995 Annual Report to 
Stockholders, a copy of which is filed as Exhibit 13 to this Report.

ITEM 6 - SELECTED FINANCIAL DATA

The information required by this Item is incorporated herein by reference to 
the Financial Summary on pages 56 and 57 of the Company's 1995 Annual Report 
to Stockholders, a copy of which is filed as Exhibit 13 to this Report.



ITEM 7 - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND 
RESULTS OF OPERATIONS

The information required by this Item is incorporated herein by reference to 
pages 28 through 33 of the Company's 1995 Annual Report to Stockholders, a 
copy of which is filed as Exhibit 13 to this Report.

ITEM 8 - FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

The information required by this Item is incorporated herein by reference to 
pages 34 through 53 and the Selected Quarterly Financial Data (unaudited) on 
page 58 of the Company's 1995 Annual Report to Stockholders, a copy of which 
is filed as Exhibit 13 to this Report.

ITEM 9 - CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND 
FINANCIAL DISCLOSURE

Not applicable.

PART III

ITEM 10 - DIRECTORS OF THE REGISTRANT

The information required by this Item relating to Directors is incorporated 
herein by reference to pages 3 through 7 of the Company's proxy statement 
dated July 25, 1995, to be filed with the Securities and Exchange Commission 
pursuant to Section 14(a) of the Securities Exchange Act of 1934.

ITEM 11 - EXECUTIVE COMPENSATION

The information required by this Item is incorporated herein by reference to 
pages 7 through 9 of the Company's proxy statement dated July 25, 1995, to 
be filed with the Securities and Exchange Commission pursuant to Section 
14(a) of the Securities Exchange Act of 1934.

ITEM 12 - SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The information required by this Item is incorporated herein by reference to 
pages 2 and 3 of the Company's proxy statement dated July 25, 1995, to be 
filed with the Securities and Exchange Commission pursuant to Section 14(a) 
of the Securities Exchange Act of 1934.

ITEM 13 - CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

The information required by this Item is incorporated herein by reference to 
page 11 of the Company's proxy statement dated July 25, 1995, to be filed 
with the Securities and Exchange Commission pursuant to Section 14(a) of the 
Securities Exchange Act of 1934.

PART IV

ITEM 14 - EXHIBITS, FINANCIAL STATEMENT SCHEDULES AND REPORTS ON FORM 8-K

  (a)(1)    Financial Statements of the Company

The following financial statements of Fluke Corporation and Subsidiaries are 
incorporated herein by reference to pages 34 through 58 of the Company's 
1995 Annual Report to Stockholders, a copy of which is filed as Exhibit 13 
to this report.

1.  Consolidated Balance Sheets as of April 28, 1995 and April 29, 1994.

2.  Consolidated Statements of Income for the year ended April 28, 1995, the 
year ended April 29, 1994, for the seven months ended April 30, 1993 and the 
year ended September 25, 1992.

3.  Consolidated Statements of Cash Flows for the year ended April 28, 1995, 
the year ended April 29, 1994, for the seven months ended April 30, 1993 and 
the year ended September 25, 1992.

4.  Consolidated Statements of Stockholders' Equity for the year ended April 
28, 1995, the year ended April 29, 1994, for the seven months ended April 
30, 1993 and the year ended September 25, 1992.

5.  Notes to Consolidated Financial Statements.

  (a)(2)     Financial Statement Schedules

The following additional information should be read in conjunction with the 
Consolidated Financial Statements of the Company described in Item 14 
(a)(1):

Schedule II              Valuation and Qualifying Accounts

Schedules other than those listed above are omitted because they are not 
required or are not applicable, or because the information is furnished 
elsewhere in the financial statements or the notes thereto.

(a)(3) Index to Exhibits

Exhibit                                                         Page No.
No.     Exhibit                                               Sequential
                                                        Numbering System

3.    Articles of Incorporation and Bylaws 

3.1   Restated copy of Articles of Incorporation as amended on August 
      11, 1993 (incorporated by reference to Exhibit 3.1 of the 
      Company's Form 10-K Report for the Fiscal Year ended April 29, 
      1994).

3.2   Conformed Copy of Bylaws as amended through January 16, 1995

4.    Instruments Defining the Rights of Security Holders, Including 
      Indentures

4.1   Stockholders Rights Plan (incorporated by reference to the 
      Company's Form 8A Report dated July 11, 1988), the First 
      Amendment to the Stockholders Rights Plan (incorporated by 
      reference to the Company's Form 8A Report dated May 2, 1989) 
      and the Second Amendment to the Stockholders Rights Plan 
     (incorporated by reference to the Company's Form 8A report 
      dated February 15, 1990).

10.   Material Contracts

10.1  1990 Stock Incentive Plan of the Company (incorporated by 
      reference to Exhibit 10.11 of the Company's Form 10-K Report 
      for the Fiscal Year ended September 27, 1991).

10.2  Stock Option Plan for Outside Directors (incorporated by 
      reference to Exhibit 10.12 of the Company's Form 10-K Report 
      for the Fiscal Year ended September 27, 1991).

10.3  Employment Agreement dated September 5, 1991 between the 
      Company and William G. Parzybok, Jr. (incorporated by reference 
      to Exhibit 10.7 of the Company's Form 10K Report for the Fiscal 
      Year ended September 27, 1992).

10.4  Employment Agreement dated September 5, 1991 between the 
      Company and George M. Winn (incorporated by reference to 
      Exhibit 10.8 of the Company's Form 10K Report for the Fiscal 
      Year ended September 27, 1992).

10.5  Employment Agreement dated September 5, 1991 between the
      Company and Ronald R. Wambolt (incorporated by reference to
      Exhibit 10.9 of the Company's Form 10K Report for the Fiscal
      Year ended September 27, 1992).

10.6  Employment Agreement dated September 5, 1991 between the
      Company and Richard W. Van Saun (incorporated by reference to
      Exhibit 10.10 of the Company's Form 10K Report for the Fiscal
      Year ended September 27, 1992).

10.7  Change of Control Agreement dated September 5, 1991 between the
      Company and John R. Smith.  Other executive officers of the 
      Company have identical change of control agreements with the
      Company (incorporated by reference to Exhibit 10.12 of the
      Company's Form 10-K Report for the Fiscal Year ended April 30,
      1993).

10.8  Annual Variable Compensation Policy (incorporated by
      reference to Exhibit 10.17 of the Company's Form 10-K Report
      for the Fiscal Year ended April 30, 1993).

10.9  Purchase Agreement between the Company and Philips Electronics
      N.V. dated February 26, 1993 (incorporated by reference to
      Exhibit 10.18 of the Company's Form 10-K Report for the Fiscal
      Year ended April 30, 1993).

10.10 Stock Purchase Agreement between the Company and Philips
      Electronics N.V. dated May 26, 1993 (incorporated by reference
      to Exhibit 10.19 of the Company's Form 10-K Report for the
      Fiscal Year ended April 30, 1993).

10.11 Fluke Corporation 1988 Stock Incentive Plan of the Company as
      amended on June 10, 1993 by stockholders on September 29, 1993 
     (incorporated by reference to Exhibit 10.11 of the Company's
      Form 10-K Report for the Fiscal Year ended April 29, 1994

10.12 Deferred Compensation Plan for Directors of Fluke Corporation 
      as amended on April 29, 1994 (incorporated by reference to
      Exhibit 10.12 of the Company's Form 10-K Report for the Fiscal
      Year ended April 29, 1994).

10.13 Fluke Corporation Supplemental Retirement Income Plan as
      amended on June 22, 1994 (incorporated by reference to Exhibit
      10.13 of the Company's Form 10-K Report for the Fiscal Year
      ended April 29, 1994).

11    Computation of Earnings Per Share

13    1995 Annual Report to Stockholders

18    Preferability letter from Ernst and Young, independent
      auditors, dated July 22, 1993 regarding Change in Accounting
      Principle (incorporated by reference to Exhibit 18 of the
      Company's Form 10-K Report for the Fiscal Year ended April 30,
      1993).

21    Subsidiaries

23.1  Consent of Ernst & Young LLP, independent auditors, dated July 27,
      1995



Item 14 (b)Reports on Form 8-K.

No reports on Form 8-K were filed during the last quarter of the 
Company's Fiscal Year ended April 28, 1995.

Item 14 (c)Exhibits:  See "Index to Exhibits" at Item 14(a)(3) above.

Item 14 (d)Financial Statement Schedules:  Schedules required to be 
filed in response to this portion of Item 14 are listed above in Item 
14 (a)(2).


SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities 
Exchange Act of 1934, the Registrant has duly caused this report to be 
signed on its behalf by the undersigned, thereunto duly authorized.

FLUKE CORPORATION
(Registrant)

/s/ George M. Winn                           President
    George M. Winn             Chief Operating Officer          July 25, 1995

Pursuant to the requirements of the Securities Exchange Act of 1934, this 
report has been signed below by the following persons on behalf of the 
Registrant and in the capacities and on the date indicated.


Signature                                         Title                   Date
/s/ William G. Parzybok, Jr.      Chairman of the Board          July 25, 1995
    William G. Parzybok, Jr.    Chief Executive Officer
/s/ George M. Winn           President, Chief Operating          July 25, 1995
    George M. Winn                 Officer and Director
/s/ Barry L. Rowan                       Vice President          July 25, 1995
    Barry L. Rowan              Chief Financial Officer
/s/ John R. Smith             Vice President, Treasurer          July 25, 1995
    John R. Smith              Chief Accounting Officer
/s/ J. Peter Bingham                           Director          July 25, 1995
    J. Peter Bingham
/s/ Philip M. Condit                           Director          July 25, 1995
    Philip M. Condit
/s/ John D. Durbin                             Director          July 25, 1995
    John D. Durbin
/s/ David L. Fluke                             Director          July 25, 1995
    David L. Fluke
/s/ John M. Fluke, Jr.                         Director          July 25, 1995
    John M. Fluke, Jr.
/s/ Robert S. Miller, Jr.                      Director          July 25, 1995
    Robert S. Miller, Jr.
/s/ William H. Neukom                          Director          July 25, 1995
    William H. Neukom
/s/ Dr. David S. Potter                        Director          July 25, 1995
    Dr. David S. Potter
/s/ N. Stewart Rogers                          Director          July 25, 1995
    N. Stewart Rogers
/s/ Stephen C. Tumminello                      Director          July 25, 1995
    Stephen C. Tumminello
/s/ James E. Warjone                           Director          July 25, 1995
    James E. Warjone


<TABLE>
Schedule VIII
                                   VALUATION AND QUALIFYING ACCOUNTS
(in thousands)
<CAPTION>
                                                     <F1>
                                                   Column C
Column A                              Column B    Additions    Column D     Column F
                                    Balance at   Charged to               Balance at
                                     Beginning    Costs and       <F2>        End of
Classification                       of Period      Expense  Deductions       Period
<S>                                       <C>          <C>         <C>          <C>
Year ended September 25, 1992:
Allowance for Doubtful
  Accounts Receivable                     $454         $228        $276         $406

Seven months ended April 30, 1993:
Allowance for Doubtful
  Accounts Receivable                     $406         $121        $ 51         $476

Year ended April 29, 1994:
Allowance for Doubtful
  Accounts Receivable                     $476         $440        $330         $586

Year ended April 28, 1995:
Allowance for Doubtful
  Accounts Receivable                     $586         $820        $265       $1,141
<FN>
<F1> Column C(2) has been omitted because the answer would be none.
<F2> Write-off of uncollectible accounts receivable less recoveries.
</TABLE>


 


	






AMENDED AND RESTATED
BYLAWS
OF
FLUKE CORPORATION
(A corporation incorporated under
the laws of the State of Washington)


SECTION 1
Stockholders and Stockholders' Meetings

1.1 Annual Meeting.  The annual meeting of the stockholders of the 
corporation for the election of Directors and for the transaction of such 
other business as may properly come before the meeting shall be held each 
year at the principal office of the corporation, 6920 Seaway Boulevard, 
Everett, WA 98203 or at some other place, either within or without the 
State of Washington as designated by the Board of Directors (the 
Board), on the second Wednesday of September at 5 p.m (or if such 
specified day is a legal holiday, then on the next business day at the 
same time), or on such other day and time as may be set by the Board. 

1.2 New Business.  At an annual meeting of stockholders, only such new 
business shall be conducted, and only such proposals shall be acted upon, 
as shall have been brought before the annual meeting (a) by, or at the 
direction of, the Board or (b) by any stockholder of the corporation who 
complies with the notice procedures set forth in this Section 1.2.  

For a proposal to be properly brought before an annual meeting by a 
stockholder, the stockholder must have given timely notice thereof in 
writing to the Secretary of the corporation.  To be timely, a 
stockholder's notice must be delivered to, or mailed and received at, the 
principal office of the corporation not less than 70 days prior to the 
scheduled annual meeting, regardless of any postponements, deferrals or 
adjournments of that meeting to a later date; provided, however, that, if 
less than 80 days' notice or prior public disclosure of the date of the 
scheduled annual meeting is given or made, notice by the stockholder to 
be timely must be so delivered or received not later than the close of 
business on the 10th day following the earlier of the day on which such 
notice of the date of the scheduled annual meeting was mailed or the day 
on which such public disclosure was made.  

A stockholder's notice to the Secretary shall set forth as to each matter 
the stockholder proposes to bring before the annual meeting (a) a brief 
description of the proposal desired to be brought before the annual 
meeting and the reasons for conducting such business at the annual 
meeting, (b) the name and address, as they appear on the corporation's 
books, of the stockholder proposing such business and any other 
stockholders known by such stockholder to be supporting such proposal, 
(c) the class and number of shares of stock of the corporation which are 
beneficially owned by the stockholder on the date of such stockholder 
notice and by any other stockholders known by such stockholder to be 
supporting such proposal on the date of such stockholder notice, and (d) 
any financial interest of the stockholder in such proposal.

The Board may reject any stockholder proposal not timely made in 
accordance with the terms of this Section 1.2.  If the Board, or a 
designated committee thereof, determines that the information provided in 
a stockholder's notice does not satisfy the informational requirements of 
this Section 1.2 in any material respect, the Secretary shall promptly 
notify such stockholder of the deficiency in the notice.  The stockholder 
shall have an opportunity to cure the deficiency by providing additional 
information to the Secretary within such period of time, not to exceed 
five days from the date such deficiency notice is given to the 
stockholder, as the Board or such committee thereof shall reasonably 
determine.  If the deficiency is not cured within such period, or if the 
Board or such committee thereof determines that the additional 
information provided by the stockholder, together with information 
previously provided, does not satisfy the requirements of this Section 
1.2 in any material respect, then the Board may reject such stockholder's 
proposal.  

The Secretary shall notify a stockholder in writing whether such 
stockholder's proposal has been made in accordance with the time and 
informational requirements of this Section 1.2.  Notwithstanding the 
procedure set forth in this Section 1.2, if neither the Board nor such 
committee thereof makes a determination as to the validity of any 
stockholder proposal, the presiding officer of the annual meeting shall 
determine and declare at the annual meeting whether the stockholder 
proposal was made in accordance with the terms of this Section 1.2.  If 
the presiding officer determines that a stockholder proposal was made in 
accordance with the terms of this Section 1.2, ballots shall be provided 
for use at the meeting with respect to any such proposal.  If the 
presiding officer determines that a stockholder proposal was not made in 
accordance with the terms of this Section 1.2, such proposal shall not be 
acted upon at the annual meeting.

In addition to the notice procedures of this Section 1.2, stockholder 
proposals may be ruled out of order if the subject matter of the proposal 
is beyond the authority of stockholders as a matter of law, is unclear or 
is inappropriate for stockholder consideration.

1.3 Special Meetings.  Special meetings of the stockholders for any 
purpose or purposes may be called at any time by the Board, to be held at 
such date, time and place as the Board shall prescribe.  Upon the request 
of the Board, it shall be the duty of the Secretary to deliver notice of 
such special meeting of the stockholders within thirty (30) days after 
the receipt of said request.  If said Secretary shall neglect or refuse 
to deliver such notice, the Board may do so.

1.4 Notice of Meetings.  Written notice stating the date, time and place 
of the annual stockholders' meeting and, in the case of a special 
stockholders' meeting, the purpose or purposes for which the meeting is 
called, shall be delivered within the period prescribed by the Washington 
Business Corporation Act either personally or by mail, by or at the 
direction of the Secretary, to each stockholder of record entitled to 
vote at such meeting. If mailed, such notice shall be deemed to be 
delivered when deposited in the United States mail addressed to the 
stockholder at his or her address as it appears on the stock transfer 
books of the corporation, with postage thereon prepaid.



1.5 Fixing of Record Date.  For the purpose of determining stockholders 
entitled to notice of or to vote at any meeting of stockholders or any 
adjournment thereof, or entitled to receive payment of any dividend, or 
in order to make a determination of stockholders for the payment of any 
distribution, the allotment of rights, the conversion or exchange of any 
securities by their terms or any other proper purpose, the Board may fix 
in advance a date as the record date for any such determination of 
stockholders.  Such record date shall not be more than seventy (70) days 
and, in case of a meeting of stockholders, not less than ten (10) days 
prior to the date on which the particular action requiring such 
determination is to be taken.  

If no record date is fixed for the determination of stockholders entitled 
to notice of or to vote at a meeting of stockholders, or stockholders 
entitled to receive payment of a dividend, the date on which notice of 
the meeting is mailed or the date on which the resolution of the Board 
declaring such dividend is adopted, as the case may be, shall be the 
record date for such determination of stockholders.  When a determination 
of stockholders entitled to vote at any meeting of stockholders has been 
made as provided in this Section 1.5, such determination shall apply to 
any adjournment thereof, unless the Board chooses to establish a new 
record date or if the adjournment is more than one hundred twenty (120) 
days after the date of the original meeting in which case the Board must 
establish a new record date.  

1.6 List of Stockholders.  At least ten (10) days before each 
stockholders' meeting, the Secretary or the agent having charge of the 
stock transfer books of the corporation shall compile a complete list of 
the stockholders entitled to vote at such meeting or adjournment thereof, 
arranged in alphabetical order, with the address of each stockholder and 
the number of shares owned by each stockholder.  This list shall be kept 
at the principal office of the corporation for ten (10) days prior to the 
meeting, and shall be kept open at such meeting, for the inspection of 
any stockholder or any stockholder's agent.  

1.7 Quorum.  The holders of a majority of the shares entitled to vote at 
a meeting, present in person or by proxy, shall constitute a quorum of 
stockholders for the transaction of business and the act of a majority of 
the shares present in person or by proxy at a meeting at which there is a 
quorum, shall be the act of the corporation, except as otherwise provided 
by these Bylaws, the Articles of Incorporation, or the Washington 
Business Corporation Act.

1.8 Adjourned Meetings.  Whether for failure to obtain a quorum or 
otherwise, an adjournment or adjournments of any stockholders' meeting 
may be taken to such date, time and place as the majority of those 
present may determine. Notice need not be given of the new date, time and 
place if the announcement of such information is made at such meeting 
before adjournment. However if a new record date is set pursuant to 
Section 1.5, notice of the adjourned meeting must be given to 
stockholders as of the new record date.     

1.9 Proxies.  The holder of any proxy for a stockholder shall present 
evidence to the Secretary of his or her appointment by an instrument in 
writing signed by the stockholder or by his or her duly authorized 
attorney-in-fact.  No proxy shall be valid after eleven (11) months from 
the date of its execution unless otherwise provided in the proxy.  
Revocation of a stockholder's proxy shall not be effective until written 
notice thereof has actually been received by the Secretary prior to the 
start of the meeting.


SECTION 2
Board of Directors

2.1 Number and Qualification.  The business affairs and property of the 
corporation shall be managed under the direction of a Board of Directors, 
the number of members of which shall be thirteen. 

2.2 Election -Term of Office.  Directors shall hold office for the term 
set forth in this Section 2.2, and until their respective successors are 
elected and qualified, unless removed in accordance with the Articles of 
Incorporation and the Washington Business Corporation Act.  When the 
Board shall consist of fewer than nine members, each Director shall hold 
office until the next succeeding annual meeting of stockholders.  When 
the Board shall consist of nine or more members, the Directors shall be 
divided into three classes, each class to be as nearly equal in number as 
possible, the term of office of Directors of the first class to expire at 
the first annual meeting of stockholders after their election, that of 
the second class to expire at the second annual meeting after their 
election, and that of the third class to expire at the third annual 
meeting after their election.  At each annual meeting after such 
classification, the number of Directors equal to the number of the class 
whose term expires at the time of such meeting shall be elected to hold 
office until the third succeeding annual meeting.  In the event of 
failure to elect Directors at any annual stockholders' meeting, or in the 
event of failure to hold any annual stockholders' meeting as provided by 
these Bylaws, Directors may be elected at a special meeting of the 
stockholders called for that purpose.
  
2.3 Director Nominations.  Nominations of candidates for election as 
Directors at any meeting of stockholders may be made (a) by, or at the 
direction of, a majority of the Board or (b) by any stockholder entitled 
to vote at such meeting.  Only persons nominated in accordance with the 
procedures set forth in this Section 2.3 shall be eligible for election 
as Directors at a stockholders' meeting.

Nominations, other than those made by, or at the direction of, the Board, 
shall be made pursuant to timely notice in writing to the Secretary as 
set forth in this Section 2.3.  To be timely a stockholder's notice shall 
be delivered to, or mailed and received at, the principal office of the 
corporation not less than 70 days nor more than 90 days prior to the date 
of the scheduled stockholder meeting, regardless of postponements, 
deferrals, or adjournments of that meeting to a later date; provided, 
however, that if less than 80 days' notice or prior public disclosure of 
the date of the scheduled meeting is given or made, notice by the 
stockholder to be timely must be so delivered or received not later than 
the close of business on the 10th day following the earlier of the day on 
which such notice of the date of the scheduled meeting was mailed or the 
day on which such public disclosure was made.  

Such stockholder's notice shall set forth (a) as to each person whom the 
stockholder proposes to nominate for election or re-election as a 
Director and as to the stockholder giving the notice (i) the name, age, 
business address and residence address of such person, (ii) the principal 
occupation or employment of such person, (iii) the class and number of 
shares of stock of the corporation which are beneficially owned by such 
person on the date of such stockholder notice and (iv) any other 
information relating to such person that is required to be disclosed in 
solicitations of proxies with respect to nominees for election as 
Directors, pursuant to Regulation 14A under the Securities Exchange Act 
of 1934, as amended; and (b) as to the stockholder giving the notice (i) 
the name and address, as they appear on the corporation's books, of such 
stockholder and any other stockholders known by such stockholder to be 
supporting such nominees and (ii) the class and number of shares of stock 
of the corporation which are beneficially owned by such stockholder on 
the date of such stockholder notice and by any other stockholders known 
by such stockholder to be supporting such nominees on the date of such 
stockholder notice.  At the request of the Board, any person nominated 
by, or at the direction of, the Board for election as a Director at a 
stockholder meeting shall furnish to the Secretary that information 
required to be set forth in a stockholder's notice of nomination which 
pertains to the nominee.
 
No person shall be elected as a Director of the corporation unless 
nominated in accordance with the procedures set forth in this Section 
2.3.  Ballots bearing the names of all the persons who have been 
nominated for election as Directors at a stockholder meeting in 
accordance with the procedures set forth in this Section 2.3 shall be 
provided for use at the stockholder meeting.

The Board, or a designated committee thereof, may reject any nomination 
by a stockholder not timely made in accordance with the requirements of 
this Section 2.3. If the Board, or a designated committee thereof, 
determines that the information provided in a stockholder's notice does 
not satisfy the informational requirements of this Section 2.3 in any 
material respect, the Secretary shall promptly notify such stockholder of 
the deficiency in the notice.  The stockholder shall have an opportunity 
to cure the deficiency by providing additional information to the 
Secretary within such period of time, not to exceed five (5) days from 
the date such deficiency notice is given to the stockholder, as the Board 
or such committee thereof shall reasonably determine.  If the deficiency 
is not cured within such period, or if the Board or such committee 
thereof reasonably determines that the additional information provided by 
the stockholder, together with information previously provided, does not 
satisfy the requirements of this Section 2.3 in any material respect, 
then the Board may reject such stockholder's nomination.  

The Secretary shall notify a stockholder in writing whether such 
stockholder's director nomination has been made in accordance with the 
time and information requirements of this Section 2.3.  Notwithstanding 
the procedure set forth in this Section 2.3, if neither the Board nor 
such committee thereof makes a determination as to the validity of any 
nominations by a stockholder, the presiding officer of the meeting shall 
determine and declare at the meeting whether a nomination was made in 
accordance with the terms of this Section 2.3.  If the presiding officer 
determines that a nomination was made in accordance with the terms of 
this Section 2.3, ballots shall be provided for use at the meeting with 
respect to such nominee.  If the presiding officer determines that a 
nomination was not made in accordance with the terms of this Section 2.3, 
the defective nomination shall be disregarded.  

2.4 Vacancies.  Except as otherwise provided by the Washington Business 
Corporation Act, vacancies in the Board, whether caused by resignation, 
death, retirement, disqualification, removal or otherwise, may be filled 
for the remainder of the term by the affirmative vote of a majority of 
the remaining Directors though less than a quorum of the Board, except 
that Directors elected to fill vacancies occurring through an increase in 
the number of Directors shall serve until the next election of Directors 
by the stockholders.  

2.5 Quorum and Voting.  At any meeting of the Board, the presence in 
person of a majority of the authorized number of Directors shall 
constitute a quorum for the transaction of business.  If a quorum is 
present, the act of a majority of the Directors present at such meeting 
shall be the act of the Board except as may be otherwise specifically 
provided by these Bylaws, the Articles of Incorporation or the Washington 
Business Corporation Act.

2.6 Annual Meeting.  The first meeting of each newly elected Board shall 
be known as the annual meeting thereof, and shall be held immediately 
after the annual stockholders' meeting or any special stockholders' 
meeting at which a Board is elected.  Said meeting shall be held at the 
same place as such stockholders' meeting unless some other place shall be 
specified by resolution of the Board.  It shall be the duty of the Board 
at their annual meeting to elect the officers of the corporation.  

2.7 Regular Meetings.  Regular meetings of the Board, or any committee 
thereof, shall be held at such date, time and place as shall from time to 
time be fixed by resolution of the Board.  

2.8 Special Meetings.  Special meetings of the Board may be held at any 
place at any time whenever called by the Chairman of the Board and Chief 
Executive Officer, the President and Chief Operating Officer, any Vice 
President, the Secretary or the Treasurer, or any two or more Directors. 

2.9 Notice of Meetings.  No notice of the annual meeting of the Board 
shall be required. No notice of any regular Board or committee meeting 
need be given, if the date, time and place thereof shall have been fixed 
by resolution of the Board. Oral or written notice of the date, time and 
place of regular meetings not fixed by Board resolution or special 
meetings of the Board or committees thereof shall be given by the 
Secretary, or by the person calling the meeting, at least two days prior 
to the time of the meeting.  Notice of any meeting of the Board may be 
waived in writing by any Director at any time, either before or after 
such meeting, and attendance at such meeting in person shall constitute a 
waiver of notice except where a Director attends for the express purpose 
of objecting to the transaction of any business because the meeting was 
not lawfully convened.  

2.10 Directors' Action Without a Meeting.  Any action which could be 
properly taken at a meeting of the Board or committee thereof, may be 
taken without such a meeting if one or more written consents setting 
forth the action so taken shall be signed by all the Directors, or all of 
the members of the committee, as the case may be.

2.11 Committees of the Board.  The Board, by resolutions adopted by a 
majority of the entire Board, may designate from among its members an 
Executive Committee and one or more other committees.  Each such 
committee may exercise the authority of the Board to the extent provided 
in such resolution and any subsequent resolutions pertaining thereto and 
adopted in like manner, provided that the authority of each such 
committee shall be subject to the limitations set forth in the Washington 
Business Corporation Act.  Such committees shall keep minutes of their 
proceedings and make regular reports to the Board. 
 
2.12 Telephone Meetings.  Members of the Board or any committee thereof 
may participate in a meeting of such Board or committee by means of a 
conference telephone or similar communications equipment by which all 
directors participating in the meeting can hear each other during the 
meeting.  A director participating by such means is deemed to be present 
in person at such meeting.  

2.13 Compensation.  Directors shall be paid their expenses, if any, 
incurred in attending meetings of the Board or of any committee thereof, 
a fixed fee for attendance at each Board or committee meeting, a fixed 
annual retainer, any combination of the above, or such other 
consideration as may be authorized by a majority of the entire Board from 
time to time. Such payment does not preclude any Director from serving 
the corporation in any other capacity and receiving compensation 
therefor.

2.14 Rights Agreement.  Notwithstanding any of the foregoing, any action 
stated in the Rights Agreement between this corporation and the First 
National Bank of Boston dated as of July 11, 1988, as such agreement may 
be amended from time to time (the "Rights Agreement") to be taken by the 
Board after a Person has become an Acquiring Person shall require the 
presence in office of Continuing Directors and the concurrence of a 
majority of the Continuing Directors.  In connection with any action 
stated in the Rights Agreement to be taken solely by the Continuing 
Directors, the Continuing Directors shall constitute and have the full 
authority of a committee of the Board.  Capitalized terms in this 
paragraph shall have the meaning indicated in the Rights Agreement.  


SECTION 3
Officers

3.1 Officers Enumerated - Election.  The officers of the corporation 
shall be a Chairman of the Board and Chief Executive Officer, a President 
and Chief Operating Officer, one or more Vice Presidents, a Secretary and 
a Treasurer (together with one or more Assistant Secretaries and 
Assistant Treasurers if such are desired by the Board), all of whom shall 
be elected by the Board, to hold office at the pleasure of the Board.  

3.2 Qualifications.  None of the officers of the corporation need be a 
director.  Any two or more corporate offices may be held by the same 
person, except the offices of President and Secretary.  

3.3 The Chairman of the Board and Chief Executive Officer.  The Chairman 
of the Board and Chief Executive Officer (the Chairman) shall preside 
at all meetings of the Board and of the stockholders, shall report to and 
consult with the Board and shall perform such other duties as the Board 
may from time to time prescribe.

3.4 The President and Chief Operating Officer.  In the absence of the 
Chairman, the President and Chief Operating Officer (the President) 
shall preside at meetings of the Board and of the stockholders and shall 
perform such other duties as the Board may from time to time prescribe.  

3.5 The Vice President.  The Vice President shall act as President in the 
absence or disability of the President and shall perform such other 
duties as the Board, the Chairman and/or the President may from time to 
time prescribe.  

3.6 The Secretary.  The Secretary, personally or with the assistance of 
others, shall keep records of the proceedings of the Directors and 
stockholders; attest all certificates of stock in the name of the 
corporation; keep the corporate seal and affix the same to certificates 
of stock and other proper documents; keep a record of the issuance of 
certificates of stock and the transfers of the same; and perform such 
other duties as the Board, the Chairman and/or the President may from 
time to time prescribe.  

3.7 The Treasurer.  The Treasurer shall have the care and custody, and be 
responsible for, all funds and securities of the corporation, and shall 
cause to be kept regular books of account.  The Treasurer shall cause to 
be deposited all such funds and securities in the name of the corporation 
and shall perform such other duties as the Board, the Chairman and/or the 
President may from time to time prescribe.	

3.8 Vacancies.  Vacancies in any office arising from any cause may be 
filled by the Board at any regular or special meeting. 

3.9 Removal.  Any officer or agent may be removed by action of the Board 
at any time, with or without cause, but such removal shall be without 
prejudice to the contract rights, if any, of the person so removed.  
Election or appointment of an officer or agent shall not of itself create 
any contract rights.  

3.10 Other Officers and Agents.  The Board may appoint such other 
officers and agents as it shall deem necessary or expedient, who shall 
hold their office for such terms, and shall exercise such powers and 
perform such duties, as shall be determined from time to time by the 
Board. 
 

SECTION 4
Shares Certificates and Their Transfer

4.1 Issuance of Shares.  No shares of the corporation shall be issued 
unless authorized by the Board or by an authorized committee thereof 
which is specifically empowered to 	do so.

4.2 Share Certificates.  Share certificates shall be issued in numerical 
order, and each stockholder shall be entitled to a certificate signed, 
either manually or in facsimile, by the Chairman of the Board, President 
or a Vice President, and by the Secretary or an Assistant Secretary, and 
sealed, either manually or in facsimile, with the corporate seal.

4.3 Transfers.  Shares may be transferred by delivery of the certificate, 
accompanied either by an assignment in writing on the back of the 
certificate, or by a written power of attorney to sell, assign and 
transfer the same, signed by the record holder of the certificate.  
Except as otherwise specially provided by these Bylaws, no shares of 
stock shall be transferred on the books of the corporation until the 
outstanding certificate has been surrendered to the corporation.  

4.4 Loss or Destruction of Certificates.  In the event of the loss or 
destruction of any certificate, a new certificate may be issued in lieu 
thereof upon satisfactory proof of such loss or destruction, and upon the 
giving of security against loss to the corporation by bond, indemnity or 
otherwise, to the extent deemed necessary by the Board or the Secretary 
or Treasurer.  


SECTION 5
Books and Records

5.1 Records of Meetings.  The corporation shall keep as permanent 
records, minutes of all Board and stockholder meetings, a record of all 
Board actions taken by consent, and a record of all actions taken by a 
committee of the Board exercising the authority of the Board on behalf of 
the corporation.

5.2 Accounting Records.  The corporation shall maintain appropriate 
accounting records.

5.3 Stockholder Records. The corporation or its agent shall maintain a 
record of its stockholders which includes the names and addresses of all 
stockholders and the number and class of shares held by each. 

5.4 Principal Office Records.  The corporation shall maintain the 
following records at its principal office:

    a)  the Articles of Incorporation and all amendments to them 
currently in effect;
    b)  the Bylaws and all amendments to them currently in effect;
    c)  the minutes of all stockholders' meetings for the past three 
years;
    d)  the consolidated balance sheets and income statements for the 
past three years;
    e)  all written communications to the stockholders for the last three 
years; 
    f)   a list of the names and business addresses of the current 
Directors and officers; and
    g)  the most recent annual report delivered to the Washington 
Secretary of State.

5.5 Inspection of Records by Stockholders.  A stockholder of the 
corporation is entitled to inspect and copy, during regular business 
hours, the records described in Section 5.4 if the stockholder gives the 
corporation written notice of the stockholder's demand at least five 
business days before the date that the stockholder wishes to inspect and 
copy.  Other corporate records may be available to be inspected and 
copied by stockholders if such demand is made in good faith and for a 
proper purpose and complies with the requirements of the Washington 
Business Corporation Act.



SECTION 6
Fiscal Year

The fiscal year of the corporation shall be a 52/53 week fiscal year 
ending on the last Friday in April.


SECTION 7
Corporate Seal

The corporate seal of the corporation shall consist of the name of the 
corporation, the state of its incorporation and the year of its 
incorporation.


SECTION 8
Amendment of Bylaws

Except as provided in the Articles of Incorporation, these Bylaws may be 
adopted, altered, amended or repealed or new Bylaws enacted only: (i) 
upon receiving the affirmative vote of a majority of the entire Board and 
of a majority of the Continuing Directors (as defined in the Articles of 
Incorporation), voting separately and as a subclass of Directors; or (ii) 
at any annual meeting of the stockholders, if notice thereof is contained 
in the notice of such meeting, (or at any special meeting thereof duly 
called for that purpose) by the affirmative vote of the holders of eighty 
percent (80%) of the voting power of the outstanding shares of Common 
Stock, in addition to any other vote required for such action by law or 
the provisions of any other class or series of stock of the corporation. 
 


SECTION 9
Indemnification of Directors and Officers

9.1 Right to Indemnification.  Subject to Section 9.2, each person who 
was or is made a party or is threatened to be made a party to or is 
involved (including, without limitation, as a witness) in any threatened, 
pending, or completed action, suit or proceeding, whether civil, 
criminal, administrative or investigative (hereinafter a "proceeding"), 
by reason of the fact that he or she is or was a director or officer of 
the corporation or who, while a director or officer of the corporation, 
is or was serving at the request of the corporation as a director, 
officer, employee or agent of another corporation or of a partnership, 
joint venture, trust, other enterprise, or employee benefit plan, whether 
the basis of such proceeding is alleged action in an official capacity as 
a director or officer or in any other assigned capacity while serving as 
a director, officer, employee or agent, shall be indemnified and held 
harmless by the corporation to the fullest extent permitted by applicable 
law, as then in effect, without the requirement of any further approval 
or finding by the stockholders, the Board, or independent legal counsel, 
against all expense, liability and loss (including attorneys' fees, 
costs, judgments, fines, ERISA excise taxes or penalties and amounts to 
be paid in settlement) reasonably incurred or suffered by such person in 
connection therewith, and such indemnification shall continue as to a 
person who has ceased to be a director or officer and shall inure to the 
benefit of his or her heirs, executors and administrators.

9.2 Indemnification Exclusions.  Notwithstanding Section 9.1, no 
indemnification shall be provided hereunder to any such person (a) to the 
extent that such indemnification would be prohibited by the Washington 
Business Corporation Act or other applicable law as then in effect, or, 
(b) except as provided in Section 9.4, in connection with a proceeding 
(or part thereof) initiated by such person unless such proceeding (or 
part thereof) was authorized by the Board.  

9.3 Advancement of Expenses.  The right to indemnification conferred in 
this Section 9 shall include the right to be paid by the corporation the 
expenses incurred in defending any such proceeding in advance of its 
final disposition, except where the Board shall have adopted a resolution 
expressly disapproving such advancement of expenses; provided, however, 
that the payment of such expenses in advance of the final disposition of 
a proceeding shall be made only upon delivery to the corporation of an 
undertaking, by or on behalf of such director or officer, to repay all 
amounts so advanced if it shall ultimately be determined that such 
director or officer is not entitled to be indemnified under this Section 
or otherwise.  

9.4 Right to Bring Suit.  If a claim under Section 9.1 is not paid in 
full by the corporation within sixty days after a written claim has been 
received by the corporation, or if a claim for expenses incurred in 
defending a proceeding in advance of its final disposition authorized 
under Section 9.3 is not paid within twenty days after a written claim 
has been received by the corporation, the claimant may at any time 
thereafter bring suit against the corporation to recover the unpaid 
amount of the claim and, to the extent successful in whole or in part, 
the claimant shall be entitled to be paid also the expense of prosecuting 
such claim.  The claimant shall be presumed to be entitled to 
indemnification hereunder upon submission of a written claim (and, in an 
action brought to enforce a claim for expenses incurred in defending any 
proceeding in advance of its final disposition, where the required 
undertaking has been tendered to the corporation), and thereafter the 
corporation shall have the burden of proof to overcome the presumption 
that the claimant is not so entitled.  It shall be a defense to any such 
that the claimant has not met the standards of conduct which make it 
permissible hereunder or under the Washington Business Corporation Act 
for the corporation to indemnify the claimant for the amount claimed, but 
the burden of proving such defense shall be on the corporation.  

9.5 Nonexclusivity of Rights.  The right to indemnification and the 
payment of expenses incurred in defending a proceeding in advance of its 
final disposition conferred in this Section shall not be exclusive of any 
other right which any person may have or hereafter acquire under any 
statute, provision of the Articles of Incorporation or the Bylaws, 
agreement, vote of stockholders or disinterested directors or otherwise. 
 

9.6 Indemnification of Employees and Agents.  The corporation may, by 
action of its Board from time to time, provide indemnification and pay 
expenses in advance of the final disposition of a proceeding to employees 
and agents of the corporation on the same terms and with the same scope 
and effect as set out in the provisions of this Section with respect to 
the indemnification and advancement of expenses of directors and officers 
of the corporation or pursuant to rights granted pursuant to, or provided 
by, the Washington Business Corporation Act or on such other terms as the 
Board may deem proper.  

9.7 Insurance, Contracts and Funding.  The corporation may maintain 
insurance, at its expense, to protect itself and any director, officer, 
employee or agent of the corporation or who, while a director, officer, 
employee or agent of the corporation, is or was serving at the request of 
the corporation as a director, officer, employee or agent of another 
corporation, partnership, joint venture, trust or other enterprise 
against any expense, liability or loss, whether or not the corporation 
would have the power to indemnify such person against such expense, 
liability or loss under the Washington Business Corporation Act.  The 
corporation may enter into contracts with any director or officer of the 
corporation in furtherance of the provisions of this Section and may 
create a trust fund, grant a security interest or use other means 
(including, without limitation, a letter of credit) to ensure the payment 
of such amounts as may be necessary to effect indemnification as provided 
in this Section 9. 

9.8 No Diminishment of Rights.  This Section 9 may be altered or amended 
as provided in Section 8, at any time, but no such amendment shall have 
the effect of diminishing the rights of any person who is or was an 
officer or director as to any acts or omissions taken or omitted to be 
taken prior to the effective date of such amendment.  

9.9 Contract Rights.  The rights conferred by this Section 9 shall be 
deemed to be contract rights between the corporation and each person who 
is or was a director or officer.  The corporation expressly intends each 
such person to rely on the rights conferred hereby in performing his or 
her respective duties on behalf of the corporation.  


Date Amended and Restated Bylaws Adopted: January 16, 1995
 



 

 








<TABLE> 
Exhibit 11                            COMPUTATION OF EARNINGS PER SHARE 
                                     Fluke Corporation and Subsidiaries 
<CAPTION> 
                                                              Seven 
                             Year ended    Year ended  months ended    Year ended 
                              April 28,     April 29,     April 30,  September 25, 
                                  1995          1994          1993          1992 
<S>                           <C>           <C>           <C>         <C> 
Shares issued at beginning 
  of period                    8,807,391     8,807,391     8,807,391   8,807,391 
Less repurchased shares at 
  beginning of period           (908,701)   (2,464,936)   (2,472,756) (2,511,214) 
Shares outstanding at 
  beginning of period          7,898,690     6,342,455     6,334,635   6,296,177 
Net issuance of shares 
  under stock award plans, 
  weighted average              (104,444)        5,208         2,398      23,515 
Shares issued for 
  acquisiton, weighted average       ---     1,000,000           ---         --- 
Shares issued upon conversion 
  of preferred shares, 
  weighted average                   ---       538,144           ---         --- 
Weighted average shares 
  outstanding                  7,794,246     7,885,807     6,337,033   6,319,442 
Common share equivalents 
  of convertible preferred 
  shares, weighted average           ---           ---       538,144     540,578 
Assumed exercise of stock 
  options, weighted average 
  of incremental shares          198,558       145,889       194,286     173,425 
Average shares and common 
  share equivalents 
  outstanding                  7,992,804     8,031,696     7,069,463   7,033,695 
 
Earnings per share based on 
  weighted average shares 
  and common share equivalents 
  outstanding                     $ 1.86        $ 1.10        $ 0.95      $ 2.16 
Net Income (in thousands)        $14,901        $8,800        $6,743     $15,204 
</TABLE>


EXHIBIT 13

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF 
OPERATIONS

FINANCIAL RESULTS 1995 VS 1994

The financial results in 1995 showed improvement over 1994.  Revenues of 
$382.1 million were up 7 percent over revenues of $357.9 million in 1994.  
International revenues, after conversion to U.S. dollars, were up 13 percent 
in 1995, while revenues in the United States were down less than one percent.

International revenues, which increased in many markets, were led by a 30 
percent increase in Asian countries.  Countries contributing to this growth 
were South Korea, which increased over 50 percent, Singapore, increasing 
almost 100 percent and Japan and Taiwan which both grew over 30 percent.  
Revenues in Europe increased 9 percent in 1995 over 1994.  Revenues in foreign 
countries in which the Company has direct sales, when converted to U.S. 
dollars, are affected by changes in the currency exchange rate.  The 
currencies of these countries generally strengthened against the U.S. dollar, 
which caused 1995 international revenues to be approximately 5 percent higher 
than 1994 from currency movements. The Company's international revenues 
comprised 56 percent of total revenues in 1995 and 53 percent of total 
revenues in 1994.  This level of revenues from outside the United States has 
added some complexity and risk to the Company.  These risks include increased 
exposure to the risk of foreign currency fluctuations, changes in labor and 
tax laws, import and export controls and changes in governmental policies. 
Beginning January 1996, the European Union will be requiring that all 
electrical instrument sold within Europe have a "CE" mark, which indicates 
compliance with certain electromagnetic emission and susceptibility 
regulations.  The Company has embarked on a process to modify its significant 
products to conform to the CE requirements by the January 1, 1996 deadline.

Contributing to the flat revenues in the United States was a price increase at 
the beginning of fiscal 1995 which caused some movement of business to 1994, 
ahead of the price increase.  There was no significant price increase at the 
beginning of fiscal 1996.

Cost of goods sold as a percentage of revenues decreased to 49 percent in 1995 
from 51 percent in 1994.  This improvement is attributed primarily to 
increased factory utilization in 1995 over 1994 and the mix of higher margin 
new products.  Also contributing to the improvement was the shipment of 
product in 1994 which was acquired prior to the acquisition at a higher cost 
from Philips pursuant to the alliance.  The acquisition and the alliance are 
described in Note 2, Acquisition of European Operations, to the financial 
statements.  The improvement in cost of goods sold allowed gross margin to 
increase 12 percent on the 7 percent increase in revenues.  The impact of 
currency was negligible.

Operating expenses increased 7 percent in 1995 over 1994.  Approximately 3 
percent of the increase was due to the weakening U.S. dollar against the 
currencies in which the Company has foreign operations.  Marketing and 
administrative expense increased 7 percent and research and development 
expense increased 8 percent in 1995 over 1994.  The increase in marketing and 
administrative expense was due to several items including higher commission 
expense from the sale of the local area network (LAN) products, higher 
reserves for bad debts and increased legal costs related to the protection of 
intellectual property.  Research and development expense increased due to a 
continued high level of product introductions in 1995.

Four years ago, the Company developed a new mission that has been discussed in 
previous annual reports.  The implementation of the mission has had a 
significant impact on the type of products developed and on the way products 
are sold in the U.S.  The direct sales force in the U.S. was particularly 
impacted because most of these new mission-centric products are more 
effectively sold through indirect sales channels.  In March 1995, it was 
determined that the selling responsibility of products previously sold by the 
Company's direct sales force would transfer to independent representative 
organizations.  Those employees impacted by the transition have either been 
transferred to positions supporting indirect sales channels, hired by the 
representative organizations or have left the Company.  The cost of the 
transition was recorded in 1995.  There are fifteen representative 
organizations with geographic territories that will be selling the Company's 
products in the United States.  This transition provides greater coverage for 
these products and changes the cost of selling these products from a primarily 
fixed to a variable cost.

The dynamics that caused the reorganization of the U.S. sales force are also 
impacting how products are sold in international markets.  Each country is 
unique in the types of indirect sales channels that are available and in the 
ways customers make their purchases.  As the markets evolve, the Company is 
evaluating the best methods of delivering its products to customers in each 
international market.  Although there are differences between countries, the 
Company's products are increasingly sold through the various indirect channels 
and this trend is expected to continue.

The Company recorded $2.8 million in amortization expense for goodwill and 
intangible assets in 1995, most of which related to the acquisition of the 
Philips test and measurement business.  This amortization is recorded in 
marketing and administrative expense.  In 1994, this expense of $2.6 million 
was recorded in nonoperating expense, but has been reclassified to marketing 
and administrative expense in the accompanying financial statements.

The Company received a favorable settlement of $1.0 million in a legal action 
taken against a company for patent infringement of which $200,000 was 
recognized in nonoperating income in 1995.  A reserve was established for the 
remainder due to uncertainty of collectibility.  Other nonoperating activities 
in 1995 and 1994 included sales of facilities, interest income and expense and 
currency gains and losses, none of which changed significantly from year to 
year.

The effective annual tax rate increased from 37.5 percent in 1994 to 38.0 
percent in 1995.  Although the average statutory rate in Europe is close to 
the U.S. statutory rate of 35.0 percent, losses in some of the acquired 
country operations with no offsetting benefit caused the effective rate to 
exceed the statutory rate.  The Company has deferred tax assets which require 
a minimum amount of taxable income in future years to be realized.  The future 
level of income before income taxes is expected to be sufficient to realize 
the deferred tax assets, net of the recorded valuation allowance.

Net income and earnings per share both increased 69 percent in 1995 over 1994. 
This increase resulted from the 12 percent increase in gross margin while 
expenses only increased 7 percent.  The Company's emphasis on revenue growth 
through new products while controlling expenses and improving factory 
efficiencies will continue in 1996.

FINANCIAL RESULTS 1994 VS 1993

All references to 1994 are to the fiscal year ended April 29, 1994 and all 
references to 1993 are to the seven-month transition period ended April 30, 
1993.  Restated 1993 refers to the 1993 results that have been restated to 
present 1993 on a comparable twelve month period to 1994.  The transition 
period resulted from a change in the fiscal year end in 1993 from the last 
Friday in September to the last Friday in April.

Effective May 1, 1993, the Company completed the largest acquisition in its 
history with the purchase of the test and measurement business of Philips N.V. 
of the Netherlands (Philips).  The completion of the acquisition ended the 
five year strategic marketing alliance between the Company and Philips.  The 
acquisition provided the Company with several major products including 
ScopeMeter test tools, oscilloscopes, and function generators, which have been 
organized into the Company's Diagnostic Tools Division.  It also provided the 
Company with direct sales and service operations in fourteen European 
countries.  The addition of the Diagnostic Tools Division and the European 
sales operations added over 900 people to the Company, all in Europe.  
Additional financial data regarding the purchase is found in Note 2, 
Acquisition of European Operations, to the financial statements.

Net income in 1994 of $8.8 million and $1.10 per share was below historical 
levels.  The Company planned for this reduced level of profitability for 1994 
to invest in new product programs to accelerate the growth of the Company and 
offset the loss in revenues from the product lines which were discontinued or 
sold as a result of the restructuring initiative begun several years ago.  

Revenues of $357.9 million in 1994 were 46 percent higher than the $245.3 
million in restated 1993.  Excluding the contribution of the acquisition, 1994 
revenues were up slightly over the revenues of restated 1993.  The 
geographical shift in the distribution of revenues was dramatically influenced 
by the acquisition.  In 1993, the Company's U.S. revenues were 65 percent and 
international revenues were 35 percent of total revenues.  European revenues 
contributed 13 percent of the total.  In 1994, after the acquisition, U.S. 
revenues were 47 percent and international revenues were 53 percent of total 
revenues.  European revenues in 1994 contributed 38 percent of the total. 

Cost of goods sold as a percentage of revenues was 51 percent in 1994 compared 
to 54 percent in 1993.  The Company added manufacturing operations in the 
Netherlands as a result of the acquisition.  These new facilities produce 
instruments with a similar cost structure to the Company's facilities in the 
U.S.  The acquired products the Company formerly purchased from Philips have a 
lower manufacturing cost than the previous cost to the Company under the 
alliance agreement.  This reduction in cost of goods sold is offset to some 
degree by the increase in operating costs discussed below.  

Operating expenses as a percentage of revenues increased from 43 percent to 45 
percent.  The addition of the acquired European operations, which includes 
marketing, selling, research and development, and administrative operations, 
increased the level of the Company's operating expense.  As discussed above, 
the increased gross margin now generated on the sale of U.S. built products in 
Europe and the revenues from the acquired products support the increase in 
expense.  

Marketing and administrative expenses increased as a percentage of revenues 
from 33 percent in 1993 to 35 percent in 1994.  One factor in this increase is 
the addition of sales operations in fourteen European countries where the cost 
of selling is higher than in the U.S.

Research and development activities have remained a high priority for the 
Company.  The Company spent 9.8 percent of revenues on research and 
development in 1994 compared to 10.3 percent in 1993.  The research and 
development operations acquired from Philips have changed their focus to 
products that fit the Company's mission.  In addition, to supplement the 
development resources, the Company has purchased some of its new products, 
such as the Company's first LAN product offerings.  This allows the Company to 
get products to the market faster and then integrate this expertise into the 
Company.

Goodwill of $20.8 million and intangible assets of $7.7 million were recorded 
as a result of the acquisition.  The goodwill is being amortized over 20 years 
and the intangible assets are being amortized over five years.  Amortization 
expense of $2.6 million related to the intangible assets and goodwill as a 
result of the acquisition are recorded in marketing and administrative 
expense.

The effective annual tax rate increased from 28.2 percent in 1993 to 37.5 
percent in 1994.  The rate increase was caused primarily by the addition of 
the European operations and partially by the increase in the U.S. statutory 
rate to 35 percent.  Although the average statutory rate in Europe is close to 
the U.S. statutory rate, losses in some of the acquired country operations 
with no offsetting benefit caused the increase in the overall rate.  The 
effective annual tax rates in 1993 and 1992 were below the U.S. statutory rate 
of 34 percent, in those years, due to the utilization of existing foreign tax 
credit carryovers and the benefit of the Company's Foreign Sales Corporation. 
 The significant foreign tax credit carryovers have been utilized, and in 
future years, foreign tax credits are not expected to influence the effective 
annual tax rate.

FINANCIAL RESULTS 1993 VS 1992

In this section, all references to 1993 are for the audited seven-month 
transition period ended April 30, 1993 and all references to restated 1992 are 
for the unaudited seven-month period ended May 1, 1992.

During 1993, the Company recorded two changes in accounting policies.  The 
Company adopted Statement of Financial Accounting Standards Number 109, 
"Accounting for Income Taxes."  The cumulative effect of adopting the 
statement was a positive adjustment to income of $1.5 million.  The Company 
also changed the method used in applying overhead costs to inventory.  
Overhead costs related to the procurement process are applied to inventory at 
the time of the receipt of the inventory.  Previously, these costs were 
applied during the production process.  The cumulative effect of this change 
was a positive adjustment to income of $2.4 million, net of tax.  The effect 
of these changes on 1993 net income before the adjustment was not significant. 
Prior years' financial statements were not restated for either item.

Revenues of $132.1 million in 1993 were 17 percent less than revenues of 
$158.7 million in restated 1992.  Almost every region of the world experienced 
revenue declines, including the U.S. which was down 18 percent and Europe, 
primarily sales to Philips, which decreased 28 percent.  Contributing to the 
decline in 1993 were lower revenues from the ScopeMeter test tools than during 
the very successful introduction year of 1992.

Revenues in the U.S. were significantly affected by the depressed economic 
conditions as customers reduced their capital purchases in response to 
economic pressures.  The Company continued to be affected by the decline in 
purchases by the U.S. government.  To mitigate this decline in U.S. government 
business, the Company expanded into new market segments.  The Company expanded 
its product offering in the automotive test market and entered the LAN market. 
The Company has continued to invest in the development of new products; 
however, only a few products were introduced in the 1993 transition period.

Operating expenses decreased 4 percent in 1993 from restated 1992, but 
increased significantly as a percentage of revenues.  The Company instigated 
several cost cutting measures in 1993 to reduce expenses.  These included 
delaying salary increases for several months and requiring days off without 
pay or temporarily reducing the pay of employees and directors.  In addition, 
the Company reduced employees through attrition and layoffs.

Marketing and administrative expenses declined 7 percent, due primarily to 
decreased expenses of the U.S. sales operation.  During 1992 and 1993, fifteen 
sales offices in smaller markets were closed and the sales employees then 
worked out of their homes.  The expense for research and development increased 
6 percent in 1993 over 1992.  The increase had been planned; consequently, the 
cost cutting measures, other than salary reductions, did not impact research 
and development to the same extent that other areas were affected.

LIQUIDITY AND CAPITAL RESOURCES

The cash position of the Company has continued to improve as cash generated 
from operating activities remains strong.  The borrowing under the Company's 
long term lines of credit remains over $20 million.  The borrowings are 
utilized for working capital requirements in the European operations.  It is 
expected that these borrowings will be repaid with cash generated from 
operations.

On June 24, 1994, the Company purchased 150,000 shares of the Company's common 
stock from Philips for $4.6 million or $30.53 per share.  The purchase of the 
shares was made according to an agreement between the two companies which 
allows Philips to sell a set number of shares over a defined period.  Under 
the agreement, the Company has the right to purchase any shares Philips offers 
for sale or can allow them to be sold on the open market, under certain 
conditions.  After the transaction, Philips owned approximately 1.4 million 
shares.  Philips offered an additional 250,000 shares in April 1995.  The 
Company did not exercise its right of first refusal and these shares have been 
registered and may now be sold by Philips.

The Company made capital expenditures of $14.1 million in 1995, $13.1 million 
in 1994, $6.2 million in the seven months ended April 30,1993 and $9.3 million 
in 1992.  Capital expenditures primarily relate to manufacturing and research 
and development equipment.  Capital expenditures in 1995 and 1994 have 
increased due to investment in computer systems for the European operations 
acquired at the beginning of 1994 and new manufacturing equipment.

The current ratio was 3.08 to 1 at April 28, 1995 and 2.74 to 1 at April 29, 
1994.  The increase in the current ratios was caused primarily by an increase 
in cash from operations.

The Company's exposure to foreign exchange currency fluctuations has increased 
since the purchase of the European operations from Philips on May 1, 1993.  
The currencies of most of the countries in which the Company operates 
strengthened during fiscal 1995, which causes the local currency assets to 
increase when stated in U.S. dollars.  Goodwill and intangible assets, which 
are recorded primarily in Dutch guilders, increased approximately $2.7 million 
as a result of the change in the currency translation rate.

The Company has a program to hedge some of its foreign exchange exposure using 
forward exchange contracts.  The contracts cannot be speculative and are 
limited to actual transaction exposure.  The Company does not currently use 
any other form of derivatives in managing its financial risk.


<TABLE>
                                FLUKE CORPORATION AND SUBSIDIARIES
                                   CONSOLIDATED BALANCE SHEETS
In thousands except shares and per share amounts
<CAPTION>
                                     April 28, 1995  April 29, 1994
<S>                                        <C>             <C>     
ASSETS
Current Assets
  Cash and cash equivalents                $ 28,880        $  6,520
  Accounts receivable (less allowances:
     1995-$1,141; 1994-$586)                 77,222          70,510
  Inventories                                53,908          54,365
  Deferred income taxes                      15,159          13,109
  Prepaid expenses                            7,556           9,914
     Total Current Assets                   182,725         154,418

Property, Plant and Equipment
  Land                                        5,979           6,181
  Buildings                                  47,235          46,661
  Machinery and equipment                   103,968          93,406
  Construction in progress                    2,298           2,440
                                            159,480         148,688
  Less accumulated depreciation             (97,611)        (88,412)
     Net Property, Plant and Equipment       61,869          60,276
Goodwill and Other Intangible Assets         23,033          24,995
Other Assets                                  7,895           5,913
Total Assets                               $275,522        $245,602

LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities
  Accounts payable                         $ 17,080        $ 19,413
  Accrued liabilities                        38,733          35,454
  Accrued liabilities related
  to restructuring                              ---             676
  Income taxes payable                        3,307             665
  Current maturities of long-term
    obligations                                 230             235
  Total Current Liabilities                  59,350          56,443
Long-Term Obligations                        21,613          14,712
Deferred Income Taxes                         9,409           9,152
Other Liabilities                             9,870           7,466
     Total Liabilities                      100,242          87,773
Stockholders' Equity
  Preferred stock, $0.25 par value 
  (authorized 2,000,000 shares)                 ---             ---
  Common stock, $0.25 par value 
  (authorized 20,000,000 shares, issued 
  including repurchased and nonvested
  shares, 7,898,674 in 1995 and 8,807,391 
     in 1994)                                 1,975           2,202
  Additional paid-in capital                 60,006          81,081
  Retained earnings                         107,089          96,553
                                            169,070         179,836
  Less repurchased shares, at cost              ---         (19,542)
  Less nonvested shares                        (145)           (362)
  Cumulative translation adjustment           6,355          (2,103)
     Total Stockholders' Equity             175,280         157,829
Total Liabilities and Stockholders' Equity $275,522        $245,602
</TABLE> 
The accompanying notes are an integral part of the financial statements.

<TABLE>
                                   FLUKE CORPORATION AND SUBSIDIARIES
                                   CONSOLIDATED STATEMENTS OF INCOME
In thousands except shares and per share amounts
<CAPTION>
                                                                   For the
                                                                     seven
                                           For the     For the      months     For the
                                        year ended  year ended       ended  year ended
                                             April       April       April   September
                                          28, 1995    29, 1994    30, 1993    25, 1992
<S>                                      <C>         <C>         <C>          <C>
Revenues                                  $382,066    $357,904    $132,139    $271,819
Cost of Goods Sold                         185,873     182,475      72,167     149,776
Gross Margin                               196,193     175,429      59,972     122,043
Operating Expenses
  Marketing and administrative             134,343     126,088      42,986      79,197
  Research and development                  37,665      34,952      13,671      22,515
     Total Operating Expenses              172,008     161,040      56,657     101,712
Operating Income                            24,185      14,389       3,315      20,331
Nonoperating Expenses (Income)
  Interest expense                           1,435       1,529          24         254
  Other                                     (1,284)     (1,220)       (666)     (1,109)
     Total Nonoperating Expenses (Income)      151         309        (642)       (855)
Income Before Income Taxes and 
  Cumulative Effect of Changes in 
  Accounting Principles                     24,034      14,080       3,957      21,186
Provision for Income Taxes                   9,133       5,280       1,116       5,982
Income Before Cumulative Effect of
  Changes in Accounting Principles          14,901       8,800       2,841      15,204
Cumulative Effect on Prior Years
  (to September 26, 1992) of a Change
  in Accounting for Inventories, Net of Tax      ---         ---       2,423         ---
Cumulative Effect on Prior Years
  (to September 26, 1992) of a Change
  in  Accounting for Income Taxes              ---         ---       1,479         ---
Net Income                                $ 14,901    $  8,800    $  6,743    $ 15,204

Per Share Amounts:
Income Before Cumulative Effect of
  Changes in Accounting Principles        $   1.86    $   1.10    $   0.40    $   2.16
Cumulative Effect of Accounting Changes:
  Accounting for inventories                   ---         ---    $   0.34         ---
  Accounting for income taxes                  ---         ---    $   0.21         ---
Earnings Per Share                        $   1.86    $   1.10    $   0.95    $   2.16
Average Shares and Share Equivalents
  Outstanding                            7,992,804   8,031,696   7,069,463   7,033,695
Pro Forma Amounts Assuming the Change
  in Accounting for Inventories is
  Applied Retroactively:
    Net Income                            $ 14,901    $  8,800    $  4,320    $ 14,938
    Earnings Per Share                    $   1.86    $   1.10    $   0.61    $   2.12
</TABLE>
The accompanying notes are an integral part of the financial statements.

<TABLE>
                                  FLUKE CORPORATION AND SUBSIDIARIES
                                 CONSOLIDATED STATEMENTS OF CASH FLOWS
In thousands
<CAPTION>
                                                                   For the
                                                                     seven
                                           For the     For the      months     For the
                                        year ended  year ended       ended  year ended
                                             April       April       April   September
                                          28, 1995    29, 1994    30, 1993    25, 1992
<S>                                      <C>          <C>         <C>        <C>
Operating Activities
Net income                                $ 14,901     $ 8,800     $ 6,743    $ 15,204
Items not affecting cash: 
  Change in accounting principles              ---         ---      (3,902)        ---
  Depreciation and amortization             16,042      17,071       7,091      11,460
  Deferred income tax                         (982)      2,381         573          47
  Accrued pension expense                    1,583      (1,162)        103        (837)
  Stock awards                                 189         376         222         680
  Loss (gain) on disposal of property,
    plant and equipment                       (251)        242         104          18
Net change in:
  Accounts receivable                       (1,016)    (45,023)     16,208        (104)
  Inventories                                4,049       4,580      (2,257)       (887)
  Prepaid expenses                           3,093      (2,356)     (1,923)       (752)
  Accounts payable                          (4,319)     12,998        (848)     (2,138)
  Accrued liabilities                           18       5,791      (3,800)      1,561
  Accrued liabilities related to
  restructuring                               (497)        892        (726)     (1,285)
  Income taxes payable                       4,505         394        (109)         25
  Other assets and liabilities              (1,804)      2,023        (895)       (299)
     Net Cash Provided By Operating 
       Activities                           35,511       7,007      16,584      22,693
Investing Activities
Additions to property, plant and equipment (14,123)    (13,050)     (6,161)     (9,337)
Proceeds from disposal of property,
  plant and equipment                        1,774         180         575         324
Purchase of Philips test and measurement
  business                                     ---     (26,056)        ---         ---
  Net Cash Used By Investing Activities    (12,349)    (38,926)     (5,586)     (9,013)
Financing Activities
Proceeds from short-term debt                  ---       2,329         775       3,257
Payments on short-term debt                    ---      (2,329)     (1,556)     (3,180)
Proceeds from long-term obligations         24,113      47,879         ---         ---
Payments on long-term obligations          (20,067)    (33,023)       (592)       (261)
Repurchase of common stock                  (4,579)        ---         ---         ---
Repurchase of preferred stock                  ---         ---         ---        (252)
Cash dividends paid                         (4,287)     (3,970)     (1,719)     (3,153)
Proceeds from stock options                  2,800         222         136         626
  Net Cash Provided (Used) By Financing
    Activities                              (2,020)     11,108      (2,956)     (2,963)
Effect of Foreign Currency Exchange Rates
  on Cash and Cash Equivalents               1,218       2,916         ---         ---
Net Increase (Decrease) In Cash and Cash
  Equivalents                               22,360     (17,895)      8,042      10,717
Cash and Cash Equivalents at Beginning
  of Period                                  6,520      24,415      16,373       5,656
Cash and Cash Equivalents at End of
  Period                                  $ 28,880     $ 6,520     $24,415    $ 16,373
Supplemental Cash Flow Information:
  Income taxes paid                       $  5,809     $ 5,142     $   826    $  5,544
  Interest paid                           $  1,409     $ 1,529     $    24    $    254
</TABLE>
The accompanying notes are an integral part of the financial statements.


<TABLE>
                                               FLUKE CORPORATION AND SUBSIDIARIES
                                         CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
In thousands except shares
<CAPTION>
                                                   Number of         Par        Par             
                                                      Common    Value of   Value of   Additional
                                                      Shares   Preferred     Common      Paid-In
                                                 Outstanding       Stock      Stock      Capital
<S>                                               <C>              <C>      <C>         <C>    
Balance, September 27, 1991                        6,296,177        $ 20     $2,202      $96,537
Net income                                                                                      
Net forfeiture of shares under stock award plans      (1,942)                                 10
Vesting of 41,516 shares under stock award plans                                                
Cash dividends declared                                                                         
Income tax benefit from stock award plans                                                     60
Repurchase of 1,538 preferred shares                                                        (252)
Exercise of stock options                             40,400                                (308)
Balance, September 25, 1992                        6,334,635        $ 20     $2,202      $96,047
Net income                                                                                      
Net issuance of shares under stock award plans           220                                  11
Vesting of 27,394 shares under stock award plans                                                
Cash dividends declared                                                                         
Income tax benefit from stock award plans                                                     54
Exercise of stock options                              7,600                                 (40)
Balance, April 30, 1993                            6,342,455        $ 20     $2,202      $96,072
Net income                                                                                      
Net forfeiture of shares under stock award plans      (5,109)                                145
Vesting of 17,117 shares under stock award plans                                                
Issuance of shares for acquisition                 1,000,000                              (1,450)
Conversion of preferred shares                       538,144         (20)                (13,361)
Cash dividends declared                                                                         
Income tax benefit from stock award plans                                                     30
Exercise of stock options                             23,200                                (355)
Net translation adjustment                                                                     
Balance, April 29, 1994                            7,898,690         ---     $2,202      $81,081
Net income                                                                                      
Net forfeiture of shares under stock award plans        (934)                                  3
Vesting of 9,524 shares under stock award plans                                                 
Repurchase of common shares                         (150,000)                                   
Income tax benefit from stock award plans                                                     35
Cash dividends declared                                                                         
Exercise of stock options                            150,918                     26        1,588
Net translation adjustment                                                                      
Cancellation of repurchased shares                                             (253)     (22,701)
Balance, April 28, 1995                             7,898,674         ---      1,975       60,006


                                               FLUKE CORPORATION AND SUBSIDIARIES
                                         CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY 
In thousands except shares
<CAPTION>
                                                           Repurchased
                                                                   and   Cumulative         Total
                                                  Retained   Nonvested  Translation  Stockholders'
                                                  Earnings      Shares   Adjustment        Equity
<S>                                               <C>        <C>           <C>          <C>    
Balance, September 27, 1991                        $74,991    $(57,485)         ---      $116,265
Net income                                          15,204                                 15,204
Net forfeiture of shares under stock award plans                   (10)                       ---
Vesting of 41,516 shares under stock award plans                   855                        855
Cash dividends declared                             (3,294)                                (3,294)
Income tax benefit from stock award plans                                                      60
Repurchase of 1,538 preferred shares                                                         (252)
Exercise of stock options                                          934                        626
Balance, September 25, 1992                        $86,901    $(55,706)         ---      $129,464
Net income                                           6,743                                  6,743
Net issuance of shares under stock award plans                     (11)                       ---
Vesting of 27,394 shares under stock award plans                   578                        578
Cash dividends declared                             (1,788)                                (1,788)
Income tax benefit from stock award plans                                                      54
Exercise of stock options                                          176                        136
Balance, April 30, 1993                            $91,856    $(54,963)         ---      $135,187
Net income                                           8,800                                  8,800
Net forfeiture of shares under stock award plans                  (145)                       ---
Vesting of 17,117 shares under stock award plans                   352                        352
Issuance of shares for acquisition                              20,894                     19,444
Conversion of preferred shares                                  13,381                        ---
Cash dividends declared                             (4,103)                                (4,103)
Income tax benefit from stock award plans                                                      30
Exercise of stock options                                          577                        222
Net translation adjustment                                                   (2,103)       (2,103)
Balance, April 29, 1994                            $96,553    $(19,904)     $(2,103)     $157,829
Net income                                          14,901                                 14,901
Net forfeiture of shares under stock award plans                    (3)                       ---
Vesting of 9,524 shares under stock award plans                    201                        201
Repurchase of common shares                                     (4,579)                    (4,579)
Income tax benefit from stock award plans                                                      35
Cash dividends declared                             (4,365)                                (4,365)
Exercise of stock options                                        1,186                      2,800
Net translation adjustment                                                    8,458         8,458
Cancellation of repurchased shares                              22,954                        ---
Balance, April 28, 1995                            107,089        (145)       6,355      $175,280
</TABLE>
The accompanying notes are an integral part of the financial statements.


NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Note 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

ACCOUNTING PERIOD.  Fluke Corporation utilizes a 52/53-week fiscal year ending 
on the last Friday in April.  Fiscal 1993 was a seven-month transition period 
ending on April 30, 1993.  Prior to fiscal 1993, the Company utilized a 52/53-
week fiscal year ending on the last Friday in September.  The accompanying 
financial statements include audited consolidated financial statements for the 
seven-month transition period ended April 30, 1993.

PRINCIPLES OF CONSOLIDATION.  The consolidated financial statements include 
the accounts of the Company and its subsidiaries.  All significant 
intercompany accounts and transactions have been eliminated.

REVENUE RECOGNITION.  Revenue is recognized at the time product is shipped or 
service is rendered to an unaffiliated customer.  Revenue from service 
contracts is recognized ratably over the lives of the contracts.

TRANSLATION OF FOREIGN CURRENCIES.  The local currency is deemed to be the 
functional currency in most of the Company's foreign operations.  In these 
operations, translation gains and losses resulting from converting the local 
financial statements to U.S. dollar financial statements are recorded in the 
Cumulative Translation Adjustment account in the equity section of the balance 
sheet.  In the remaining foreign operations, the U.S. dollar is deemed to be 
the functional currency.  In these operations, translation gains or losses are 
included in the statements of income.

CASH AND CASH EQUIVALENTS.  Cash and cash equivalents include cash on hand and 
highly liquid, short-term investments with an original maturity of less than 
three months.

INVENTORIES.  Inventories are valued at the lower of cost or market with cost 
being currently adjusted standard cost, which approximates cost on a first-in, 
first-out basis.

PROPERTY, PLANT AND EQUIPMENT.  Property, plant and equipment, including 
improvements and major renewals, are stated at cost.  Maintenance and repairs 
are expensed as incurred.  Depreciation is calculated over the estimated 
useful lives of the related assets on the straight-line basis for financial 
statement purposes, while an accelerated method is generally used for income 
tax purposes.

INCOME TAXES.  The provision for income taxes is computed on pretax income 
reported in the financial statements.  The provision differs from income taxes 
currently payable because certain items of income and expense are recognized 
in different periods for financial statement and tax return purposes.  
Deferred income taxes have been recorded using the liability method in 
recognition of these temporary differences.  The Company has provided for U.S. 
and foreign taxes on all of the undistributed earnings of its foreign 
subsidiaries that are expected to be repatriated.

EARNINGS PER SHARE.  Earnings per share is based on the weighted average 
number of common shares and share equivalents outstanding during the fiscal 
year.  Stock options are considered common stock equivalents and their 
dilutive effect is included in the earnings per share calculation.

GOODWILL AND INTANGIBLES.  Excess cost over the fair value of net assets 
acquired (goodwill) is generally amortized on a straight-line basis over 20 
years.  Intangible assets are generally amortized over 5 years.

IMPAIRMENT OF LONG-LIVED ASSETS.  Long-lived assets consist of intangible 
assets, goodwill and certain capital assets.  The carrying value of these 
assets is regularly reviewed to verify they are valued properly.  If the facts 
and circumstances suggest that the value has been impaired, the carrying value 
of the assets will be reduced appropriately.

RECLASSIFICATION.  Certain items have been reclassified to conform to the 1995 
presentation with no effect on previously reported net income.

Note 2. ACQUISITION OF EUROPEAN OPERATIONS

On May 26, 1993, the Company completed the acquisition of the test and 
measurement business of Philips Electronics N.V. of the Netherlands (Philips) 
with an effective date of May 1, 1993.  Since 1987, the Company and Philips 
had a strategic alliance pursuant to which Philips sold the Company's products 
in Europe and other selected markets and the Company sold Philips' products in 
North America and other selected markets.

The Company acquired manufacturing operations in the Netherlands, engineering 
groups in the Netherlands and Germany and sales and service operations in 
fourteen European countries.  The headquarters of the Company's Diagnostic 
Tools Division is in Almelo, the Netherlands.  The division is responsible for 
several major products including ScopeMeter test tools, oscilloscopes, and 
function generators.  The European sales and service headquarters are located 
in Eindhoven, the Netherlands.  

The purchase price for the Philips test and measurement business was 
approximately $41.8 million in cash and stock.  The cash portion was financed 
with the Company's cash and utilization of a portion of its $55.0 million 
lines of credit obtained specifically to finance the acquisition.  The stock 
component consisted of one million shares of the Company's common stock, which 
were issued from repurchased shares.  The Series A Convertible Preferred Stock 
that Philips owned was converted to common shares at the rate stated in the 
preferred stock agreement, or 538,144 shares of common stock.  After the 
transaction, Philips owned 1,538,144 shares of the Company's common stock, or 
approximately 19.5 percent of the shares then outstanding.  There are 
restrictions on Philips' ability to sell the shares, and the Company has the 
option to buy the shares before they can be offered for sale to a third party. 
Accordingly, the stock was recorded at a 15 percent discount from the market 
value at date of issue.  In May 1994, Philips offered for sale 150,000 shares, 
as allowed under the agreement.  The Company exercised its right to purchase 
the shares at a price of $30.53 per share for a total of $4.6 million.  In 
April 1995, Philips offered for sale an additional 250,000 shares, as allowed 
under the agreement.  The Company did not exercise its right of first refusal 
and these shares have been registered and may now be sold by Philips.

The Company recorded the acquisition under the purchase method of accounting. 
The components of the purchase price are as follows:
<TABLE>
(in thousands)
<S>                                                                    <C>
One million shares of the Company's common stock,
     at a fair value of $19.44 per share                               $19,444
Net cash paid for purchase                                              22,365
Purchase price                                                          41,809

Acquisition costs                                                        3,700

Purchase price and related acquisition costs                           $45,509

The allocation of the purchase price is as follows:

(in thousands)

Inventories                                                            $15,800
Prepaid expenses and other current assets                                2,668
Plant, machinery and equipment                                           6,801
Intangible assets                                                        7,700

Deferred tax assets
     Gross value                                                        27,297
     Less:  valuation reserve                                          (18,000)
     Net value                                                           9,297
Deferred tax liability                                                  (3,001)
Accrued expenses and other liabilities                                 (14,573)
Goodwill                                                                20,817

Purchase price and related acquisition costs                           $45,509
</TABLE>

As part of the acquisition, the Company entered into service agreements and 
facility leases with Philips related to the European operations.  The Company 
paid Philips $10.5 million in 1995 and $18.3 million in 1994 for such services 
and facilities lease rent.  In addition, the Company purchased $19.8 million 
in 1995 and $16.5 million in 1994 of component parts and finished goods from 
Philips.  Before the completion of the acquisition in 1994, aggregate sales 
and purchases with Philips totaled approximately $31.3 million in the seven 
months ended April 30, 1993 and $71.5 million in 1992. 

<TABLE>
Note 3. INVENTORIES
(in thousands)
<CAPTION>
                                   April 28, 1995     April 29, 1994
<S>                                       <C>                <C>    
Finished goods                            $17,483            $17,904
Work-in-process                            10,818             10,390
Purchased parts and materials              25,607             26,071
Total Inventories                         $53,908            $54,365
</TABLE>

Effective in fiscal 1993, the Company changed its method of applying overhead 
costs to inventories.  Previously, all overhead costs were applied to 
inventory during the production process based on various methods such as labor 
or machine hours.  Under the new method, certain overhead costs are applied to 
purchased parts at the time inventory is received based on related procurement 
activities, and the remaining overhead costs are applied to inventories during 
the production process.  The change was made to improve the accuracy of 
inventory valuation by applying overhead costs to inventories as the costs are 
incurred.  The change in accounting for inventories is recorded as a 
cumulative effect of a change in an accounting principle, which had the effect 
of increasing 1993 net income by $2.4 million (net of income tax in the amount 
of $952,000).  This change had no significant impact on 1993 income before 
cumulative effect of accounting changes.  The financial statements have not 
been restated to reflect this accounting change; however, pro forma 
information, as if the change were made retroactively, is shown on the 
Consolidated Statements of Income.

<TABLE>
Note 4. ACCRUED LIABILITIES
(In thousands)
<CAPTION>
                                       April 28, 1995   April 29, 1994
<S>                                           <C>              <C>    
Compensation payable                          $11,674          $ 9,674
Retirement plans contributions payable            378              960
Self-insured plans                                843            1,003
Accrued expenses                               14,180           15,619
Unearned service revenue                        3,009            2,358
Other taxes payable                             6,056            3,913
Profit-sharing bonus payable                    1,265              693
Dividends payable                               1,106            1,027
Other items                                       222              207
Total Accrued Liabilities                     $38,733          $35,454
</TABLE>

Note 5. GOODWILL AND INTANGIBLE ASSETS

Goodwill represents the excess of the purchase price over the fair market 
value of the net assets acquired in the purchase of the European operations 
from Philips.  The goodwill is being amortized on a straight-line basis over 
twenty years.  The Company owns intangible assets, most of which were also 
acquired from Philips as part of the acquisition.  These intangible assets are 
being amortized over five years. Amortization expense is recorded in marketing 
and administrative expense.  Amortization expense of goodwill and intangible 
assets had been reported in nonoperating expense prior to 1995.  Amortization 
expense has been reclassified in applicable prior periods to conform to the 
presentation in the 1995 financial statements.  Cumulative amortization was 
$6.0 million at April 28, 1995 and $2.6 million at April 29, 1994.

Goodwill and intangible assets, net of accumulated amortization, are as 
follows:
<TABLE>
In thousands
<CAPTION>
                                       April 28, 1995  April 29, 1994
<S>                                          <C>              <C>
Balance at beginning of year                  $24,995             ---
Addition resulting from acquisition               ---         $28,517
Amortization expense                           (2,764)         (2,630)
Adjustment related to changes to
   deferred tax asset valuation
   allowance<F1>                               (1,925)           (811)
Translation adjustment                          2,727             (81)
Balance at end of year                        $23,033         $24,995

<FN>
<F1> This adjustment is explained in Note 6.  Income Taxes.
</FN>
</TABLE>

Note 6.  INCOME TAXES

Effective September 26, 1992, the Company adopted Statement of Financial 
Accounting Standards No. 109 (SFAS 109), "Accounting for Income Taxes".  
Adoption of SFAS 109 required the Company to change from the deferred method 
to the liability method of accounting for deferred income taxes.  Under the 
liability method, deferred income taxes reflect the net tax effects of 
temporary differences between carrying amounts of assets and liabilities for 
financial reporting and the amounts used for tax purposes.  Deferred income 
taxes are measured using the enacted tax rates and laws that will be in effect 
when the differences are expected to reverse.  Prior to the adoption of SFAS 
109, income tax expense was determined using the deferred method.  Deferred 
tax expense was based on items of income and expense that were reported in 
different years in the financial statements and tax returns and was measured 
at the tax rate in effect in the year the difference originated.

As permitted by SFAS 109, the Company elected to record the cumulative effect 
of adopting the Statement and not restate the financial statements of prior 
years.  The cumulative effect of the change increased net income in 1993 by 
$1.5 million or $0.21 per share.  The effect of the change on 1993 net income 
before the adjustment was not significant.

For financial reporting purposes, income before income taxes is as follows:

<TABLE>
(in thousands)
<CAPTION>
                  For the           For the      For the seven         For the
               year ended        year ended       months ended      year ended
           April 28, 1995    April 29, 1994     April 30, 1993  Sept. 25, 1992
<S>           <C>                <C>               <C>              <C>
U.S.           $13,017            $13,681           $3,239           $20,201
Foreign         11,017                399              718               985
               $24,034            $14,080           $3,957           $21,186
</TABLE>
The provision for income taxes is as follows:
<TABLE>
(in thousands)
<CAPTION>
                                           LIABILITY METHOD                DEFERRED METHOD
                                For the         For the    For the seven         For the
                             year ended      year ended     months ended      year ended
                         April 28, 1995  April 29, 1994   April 30, 1993  Sept. 25, 1992
<S>                             <C>             <C>              <C>             <C>
Current taxes on income:
  U.S.                           $5,239          $1,791           $  199          $5,270
  Foreign                         5,687             986              344             665
                                 10,926           2,777              543           5,935
Deferred income taxes            (1,793)          2,503              573              47
                                 $9,133          $5,280           $1,116          $5,982
</TABLE>

Significant components of the Company's deferred tax assets and liabilities 
are as follows:
<TABLE>
(in thousands)
<CAPTION>
                                          April 28,1995   April 29,1994
<S>                                        <C>                <C>      
Deferred Tax Assets:
  Accrued restructuring costs               $      2           $  237
  Accrued employee benefit expenses            2,525            4,457
  Inventory adjustments                        5,329            4,301
  Net operating loss carryforwards            25,591           21,911
  Product warranty accruals                      721              525
  Other items, net                               617              259

Total Deferred Tax Assets                     34,785           31,690
  Valuation reserve                          (19,626)         (18,581)
Net Deferred Tax Assets                     $ 15,159          $13,109
Deferred Tax Liabilities:
  Fixed asset basis differences             $  5,701           $5,774
  Foreign tax accruals and adjustments           199              231
  Pension                                      1,578            1,078
  Intangible assets                            1,870            2,057
  Other items, net                                61               12
Total Deferred Tax Liabilities              $  9,409           $9,152
</TABLE>


The deferred tax asset valuation reserves are primarily related to deferred 
tax assets of foreign operations, including Dutch net operating loss (NOL) 
carryforwards acquired in connection with the Philips acquisition.  The 
acquired foreign NOLs have an unlimited carryover period.  A substantial 
portion of these NOLs were provided for with a valuation allowance at the time 
of the acquisition.  The tax benefit from adjusting the valuation allowance of 
the acquired NOLs is recorded as a reduction of goodwill.  Reductions in 
goodwill for NOL benefit were $1,925,000 in 1995 and $811,000 in 1994.

The deferred income tax provision (benefit) under the deferred method was as 
follows:
<TABLE>
(in thousands)
<CAPTION>
                                                                 DEFERRED METHOD
                                                                         For the
                                                                      year ended
                                                              September 25, 1992
<S>                                                                       <C>   
Deferred income taxes:
  Difference between book and tax depreciation                            $  308
  Inventory adjustments                                                     (855)
  Accrued employee benefit expenses                                          248
  Repatriation of foreign earnings, net of 1993 foreign tax credits         (551)
  Accrued restructuring costs                                              1,277
  Other items, net                                                          (380)
                                                                          $   47
</TABLE>
A reconciliation from the U.S. statutory rate to the effective tax rate is as 
follows:
<TABLE>
(in thousands)
<CAPTION>                                                                    DEFERRED
                                             LIABILITY METHOD                  METHOD
                                 For the         For the    For the seven     For the
                                year ended     year ended    months ended    year ended
                             Apr. 28, 1995  Apr. 29, 1994   Apr. 30, 1993 Sept. 25, 1992
                                Amt    Pct     Amt    Pct     Amt    Pct     Amt    Pct

<S>                         <C>      <C>    <C>    <C>     <C>     <C>    <C>     <C>
Tax at U.S. statutory rate   $ 8,412  35.0%  $4,928  35.0%  $1,345  34.0%  $7,203  34.0%
Foreign tax greater (less)
  than U.S. statutory rate       847   3.5    1,528  10.8       (5) (0.1)     161   0.7
Utilization of foreign tax 
  credits                        (35) (0.1)  (1,538)(10.9)    (129) (3.3)    (956) (4.5)
Foreign Sales Corporation tax
   benefit                      (436) (1.8)    (321) (2.3)    (107) (2.7)    (592) (2.8)
State taxes, net of federal 
  benefit                        211   0.8      222   1.6       53   1.3      333   1.6
Nondeductible goodwill           302   1.3      360   2.6      ---   ---      ---   ---
Other items, net                (168) (0.7)     101   0.7      (41) (1.0)    (167) (0.8)
                             $ 9,133  38.0%  $5,280  37.5%  $1,116  28.2%  $5,982  28.2%

</TABLE>

Note 7.  EMPLOYEE BENEFIT PLANS

The expense related to employee benefit plans is as follows:
<TABLE>
(in thousands)
<CAPTION>
                                   For the       For the   For the seven        For the
                                Year ended    year ended    months ended     year ended
                            April 28, 1995 April 29,1994  April 30, 1993 Sept. 25, 1992
<S>                             <C>           <C>             <C>          <C>
Pension Plan, U.S.               $1,170        $1,147          $  738       $  901
Pension Plans, Foreign            1,281         1,519             139          210
Profit-sharing Retirement Plan      639           652             303          859
Profit-sharing Bonus Plan         2,064         1,296             ---        3,834
Other Benefit plans                 760           813             407        1,154
Total Employee Benefit Plans     $5,914        $5,427          $1,587       $6,958
</TABLE>

PENSION PLAN, U.S.  The Company's U.S. pension plan includes all U.S. 
employees with a minimum of one year of service.  Pension benefits are based 
upon years of service with the Company and the highest sixty months' average 
compensation earned.  The Company's funding policy is to contribute annually 
the amount required by ERISA.

Net periodic U.S. pension cost is as follows:

<TABLE>
(in thousands)
<CAPTION>
                                   For the        For the   For the seven        For the
                                year ended      year ended   months ended     year ended
                            April 28, 1995  April 29, 1994 April 30, 1993 Sept. 25, 1992
<S>                               <C>            <C>           <C>         <C>
Service cost                       $ 1,990        $1,917        $ 1,129     $ 1,813
Interest cost                        2,955         2,939          1,655       2,639
Return on plan assets               (3,873)       (2,590)        (1,602)     (2,013)
Net amortization and deferral           98        (1,119)          (444)     (1,538)
Net periodic pension cost           $1,170        $1,147        $   738     $   901
</TABLE>

The funding status of the plan is as follows:

<TABLE>
(in thousands)
<CAPTION>
                                        April 28, 1995  April 29, 1994
<S>                                          <C>              <C>     
Vested benefit obligation                     $ 29,069         $30,520
Accumulated benefit obligation                $ 29,640         $31,266
Projected benefit obligation                  $ 37,754         $40,925
Fair market value of plan assets                36,299          32,968
Projected benefit obligation in excess  
  of plan assets                                 1,455           7,957
Prior service cost                                 486             314
Unrecognized net loss                           (5,589)        (11,740)
Unrecognized net transition asset                  952           1,493
Additional minimum liability                        --              94
Prepaid pension asset                         $ (2,696)        $(1,882)
</TABLE>

For purposes of calculating the funding status of the plan, the weighted 
average discount rate was 8.8 percent in 1995, 8.0 percent in 1994 and 9.0 
percent in 1993 and 1992. The rate of increase in future compensation level 
used in determining the actuarial present value of the projected benefit 
obligation varied by age group and ranged from 4.3 to 5.6 percent in 1995, 
from 3.6 to 4.9 percent in 1994 and from 5.5 to 6.8 percent in 1993 and 1992.

The expected long-term rate of return on plan assets was 9.5 percent in 1995, 
10.8 percent in 1994 and 11.0 percent in 1993 and 1992.  For purposes of 
calculating the net periodic pension cost, the actuarial assumptions utilized 
are the actuarial assumptions in place at the end of the previous fiscal year 
(e.g., the fiscal 1995 net periodic pension cost was based upon the 1994 
actuarial assumptions).

Upon adoption of Statement of Financial Accounting Standards No. 87 (SFAS 87), 
"Accounting for Pensions" in 1988, the plan had an excess of plan assets, 
including accrued contributions, over projected benefit obligations (net 
transition asset) of $5.0 million.  The net transition asset is being 
amortized over a period of 9.3 years.

All of the plan's assets are stated at fair market value and consist primarily 
of common stock, fixed income securities and cash equivalents.

PENSION PLANS, FOREIGN.  The Company has various pension plans covering its 
foreign employees.  Most of these plans are defined contribution plans and are 
fully funded.  The expense for these plans was $427,000 in 1995 and $620,000 
in 1994.  The remaining plans qualify for accounting under the rules of SFAS 
87.  The tables below include only those international pension plans which 
qualify for SFAS 87 treatment.

Net periodic pension expense of foreign plans under SFAS 87 is as follows:

<TABLE>
(in thousands)
<CAPTION>
                                 For the            For the
                              year ended         year ended
                           April 28, 1995    April 29, 1994
<S>                              <C>                <C>
Service cost                      $  780             $  792
Interest cost                      1,101              1,000
Return on plan assets             (1,015)              (893)
Net amortization and deferral        (12)               ---
Net periodic pension cost         $  854             $  899
</TABLE>

The funding status of the plans is as follows:

<TABLE>
(in thousands)
<CAPTION>
                                  April 28, 1995    April 29, 1994
<S>                                   <C>                 <C>
Vested benefit obligation              $12,498             $10,357
Accumulated benefit obligation         $13,279             $11,011
Projected benefit obligation           $19,616             $16,533
Fair market value of plan assets        19,653              14,315
Projected benefit obligation in 
  excess of (less than) plan assets        (37)              2,218
Unrecognized net gain (loss)             2,558                (290)
Accrued pension liability              $ 2,521             $ 1,928
</TABLE>

The weighted average discount rate varied from 7.0 percent to 7.5 percent in 
1995 and 6.5 percent to 7.0 percent in 1994 and the rate of increase in future 
compensation levels used in determining the actuarial present values of the 
projected benefit obligation varied from 3.0 percent to 5.0 percent in 1995 
and 1994.  The long-term rate of return on plan assets was 6.5 percent in 1995 
and 1994.

PROFIT-SHARING RETIREMENT PLAN.  The Company has a profit-sharing retirement 
plan for all U.S. employees, which provides immediate eligibility and vesting. 
The Company matches the employee's salary deferrals under section 401(k) of 
the Internal Revenue Code, subject to certain profitability and dollar limits.

PROFIT-SHARING BONUS PLAN.  The Company has a profit-sharing bonus plan, which 
generally provides semiannual cash payments to certain employees.  The amount 
of each eligible employee's bonus is dependent upon their base salary in 
relation to the total base salary of all eligible employees and the operating 
performance of the Company.  No profit-sharing bonus was paid for 1993.

OTHER BENEFIT PLANS.  The Company has various other employee cash and stock 
award plans designed to recognize and compensate key employees for 
performance.

The long-term liabilities of these benefit plans constitute the major portion 
of Other Liabilities on the Balance Sheet.

Note 8.  STOCKHOLDERS' EQUITY

REPURCHASED SHARES.  On March 10, 1995, repurchased shares of the Company 
totaling 1,011,937 were canceled and retired.  Repurchased shares had been 
used to fund stock award and stock option plans.  The balance in the 
repurchased shares account was 908,701 shares in 1994.

PREFERRED STOCK.  There are 2,000,000 shares of preferred stock authorized, of 
which 250,000 shares have been designated Series A Convertible Preferred 
Stock.  On May 26, 1993, as part of the purchase of the European operations 
from Philips, the 78,462 shares of Series A Convertible Preferred Stock, which 
were owned by Philips, were converted into 538,144 shares of common stock.  
The conversion rate was established in the original preferred stock agreement. 
There were no shares of preferred stock outstanding at April 28, 1995 or April 
29, 1994.

STOCK PURCHASE PLAN.  The Company has a voluntary employee stock purchase plan 
for eligible employees.  The Company's contribution is 25 percent of the 
amount invested by the employee, plus all commissions and brokerage fees.  The 
Company's expenses related to the plan were $473,000 in 1995, $433,000 in 
1994, $252,000 for the seven months ended April 30, 1993, and $443,000 in 
1992.

DIVIDENDS.  The Company declared cash dividends of $0.56 per share in 1995, 
$0.52 per share in 1994, $0.26 per share in the seven months ended April 30, 
1993, and $0.48 per share in 1992.

STOCKHOLDER RIGHTS PLAN.  The Company has a Stockholder Rights Plan and issues 
one Right for each outstanding share of common stock.  The Rights become 
exercisable only if a person or group (an "Acquiring Person") has acquired, or 
obtained the right to acquire, 25 percent or more of the outstanding shares of 
common stock of the Company or following the commencement of a tender or 
exchange offer for acquiring such same percentage.  In the event that a person 
or group becomes an Acquiring Person, each Right, upon exercise, will entitle 
its holder (except for an Acquiring Person) to receive common stock of the 
Company (or, in certain circumstances, cash, property or other securities of 
the Company) or of any company with which the Company shall have entered into 
certain transactions having a value equal to two times the exercise price of 
the Right.  In addition, under certain circumstances, the Continuing Directors 
can require that each Right (other than Rights held by an Acquiring Person) be 
exchanged for one share of common stock.  The Company may redeem the Rights 
for $0.01 per Right at any time before they become exercisable.  The Rights do 
not entitle their holders to any voting or dividend rights and, at least until 
they become exercisable, have no dilutive effect on the earnings of the 
Company.  The plan was adopted to encourage a prospective acquirer of the 
Company to negotiate acquisition terms with the Board of Directors, including 
the Continuing Directors, to assure that the terms are in the best interests 
of the stockholders of the Company.

STOCK OPTIONS.  The Company has a 1988 and a 1990 Stock Incentive Plan.  Stock 
options granted under the 1990 plan and those granted after 1989 under the 
1988 plan are nonqualified stock options exercisable 40 percent after one 
year, 30 percent after three years and 30 percent after five years and expire 
ten years from the date of grant.  In addition, the Company has a Stock Option 
Plan for outside Directors, which was authorized in 1990 and annually grants 
nonqualified stock options to the Company's outside Directors.  Grants under 
this plan and those made in 1988 and 1989 under the 1988 Stock Incentive Plan 
are exercisable after one year and expire ten years from the date of grant.  
All options are granted at the market value on the date of grant.  The Company 
makes no charge to income in connection with stock options.  Shares reserved 
for issuance under these stock option plans totaled 2,185,000 shares at April 
28, 1995 and April 29, 1994 and 1,285,000 at April 30, 1993 and September 25, 
1992, of which 901,880 shares, 1,018,550 shares, 337,900 shares and 460,300 
shares, respectively, were available for options to be granted in the future.

<TABLE>
<CAPTION>
                                               Total Options        Price Range
<S>                                               <C>          <C>
Balance,
September 27, 1991 (229,500 options exercisable)     550,300   $11.88 to $25.75
  Granted                                            267,900   $23.81 to $30.75
  Terminated                                          (5,900)  $25.56 to $30.75
  Exercised                                          (40,400)  $11.88 to $25.75
Balance,
September 25, 1992 (204,600 options exercisable)     771,900   $11.88 to $30.75
  Granted                                            122,400   $26.00 to $26.81
  Exercised                                           (7,600)  $11.88 to $25.75
Balance,
April 30, 1993 (269,300 options exercisable)         886,700   $11.88 to $30.75
  Granted                                            246,300   $22.44 to $28.19
  Terminated                                         (26,950)  $11.88 to $30.75
  Exercised                                          (23,200)  $11.88 to $20.38
Balance,
April 29, 1994 (460,500 options exercisable)       1,082,850   $11.88 to $30.75
  Granted                                            145,300   $28.50 to $40.38
  Terminated                                         (27,130)  $22.44 to $30.75
  Exercised                                         (154,900)  $11.88 to $30.75
Balance,
April 28, 1995 (532,000 options exercisable)       1,046,120   $11.88 to $40.38

</TABLE>

Note 9. FINANCING AND COMMITMENTS

The Company has $55.0 million of committed, noncollateralized revolving lines 
of credit which were arranged specifically for the acquisition of the European 
operations from Philips.  The $55.0 million lines of credit include a $30.0 
million three year facility that was to be used to finance the acquisition and 
corporate working capital requirements and a $25.0 million multicurrency 
facility to finance the working capital requirements of the European 
operations. The committed lines of credit require certain working capital and 
other minimum financial requirements.  The Company is in compliance with all 
covenants on its lines of credit.  Under the $30.0 million revolving line 
there was nothing outstanding at April 28, 1995 and $9.5 million outstanding 
at an interest rate of 4.55% at April 29, 1994.  Under the $25.0 million 
multicurrency line, there was $21.4 million outstanding at April 28, 1995 and 
$4.8 million outstanding at April 29, 1994.  The interest rates on these 
borrowings were 5.2 percent to 11.0 percent in 1995 and 7.0 percent in 1994.  
The available amount of the multicurrency facility is reduced by $1.25 million 
each quarter beginning in the last quarter of fiscal 1995 through fiscal 1998.

The Company has $75.0 million in uncommitted lines of credit.  There was no 
debt outstanding under these lines at April 28, 1995 and April 29, 1994.  
Long-term obligations include capital lease obligations.

Approximate required aggregate principal payments of all long-term debt will 
be as follows: 1996 - $5.0 million; 1997 - $5.0 million; 1998 - $3.8 million.

The Company's operating lease expense, including leases with a term of less 
than one year, was $7.7 million in 1995(6.9 million in 1994, $2.6 million for 
the seven months ended April 30, 1993 and $4.1 million in 1992).  The 
principal leases are for various sales offices, storage facilities, data 
processing equipment and automobiles.  Most facility leases have escalation 
clauses to cover increases in direct lease expenses.  Below is a schedule of 
future minimum lease payments under operating leases that have initial 
noncancelable lease terms in excess of one year as of April 28, 1995:

<TABLE>
(in thousands)
<CAPTION>
Fiscal Year                               Facilities     Equipment       Total
<S>                                           <C>           <C>        <C>
1996                                          $4,655        $1,764     $6,419
1997                                           3,101         1,120      4,221
1998                                           2,060           548      2,608
1999                                             690            40        730
2000                                             432            14        446
                                             $10,938        $3,486    $14,424
</TABLE>

Note 10. OPERATIONS BY GEOGRAPHIC AREAS

The Company is engaged in one line of business, the manufacture and sale of 
compact, professional electronic test tools.  In the schedule below, revenues, 
income before income taxes and assets are reported based on the location of 
the Company's facilities.  Intercompany transfers of products and services are 
made at arm's length between the various geographic areas.

<TABLE>
(in thousands)
<CAPTION>
                             For the         For the   For the seven         For the
                          year ended      year ended    months ended      year ended
                      April 28, 1995  April 29, 1994  April 30, 1993  Sept. 25, 1992
<S>                        <C>             <C>             <C>             <C>
Revenues

United States:
  Sales to
  unaffiliated customers    $167,566        $168,230        $ 86,371        $179,429
  Export sales                34,419          28,410          32,236          67,081
  Interarea transfers         55,090          45,133           8,294          15,232
                             257,075         241,773         126,901         261,742
Europe:
  Sales to 
  unaffiliated customers     148,902         136,820             ---             ---
  Interarea transfers         32,620          24,952             ---             ---
                             181,522         161,772             ---             ---
Other areas:
  Sales to
  unaffiliated customers      31,179          24,444          13,532          25,309

Eliminations                 (87,710)        (70,085)         (8,294)        (15,232)

Consolidated revenues       $382,066        $357,904        $132,139        $271,819


Income before income taxes:
  United States             $ 20,571        $ 20,699        $  6,300        $ 26,301
  Europe                       7,538             228             ---             ---
  Other                        4,316           1,158             718             985
  Corporate expense and
    eliminations              (8,391)         (8,005)         (3,061)         (6,100)
Consolidated income before
  income taxes              $ 24,034        $ 14,080        $  3,957        $ 21,186

Assets:
  United States             $149,975        $141,014        $164,733        $168,004
  Europe                     112,783         108,129             ---             ---
  Other                       15,201          10,977           8,211           8,443
  Eliminations                (2,437)        (14,518)           (857)           (641)
Total Assets                $275,522        $245,602        $172,087        $175,806

</TABLE>

In previous annual reports this schedule reported revenues based on the 
location of the customer as opposed to the location of the Company's 
facilities.

Note 11.  FINANCIAL INSTRUMENTS

Financial instruments, which potentially subject the Company to concentrations 
of credit risk, consist principally of trade receivables.  As of April 28, 
1995, the Company had no significant concentrations of credit risk due to a 
large and diversified customer base spanning vast geographic areas.

The Company is subject to transaction exposures that arise from foreign 
exchange movements between the dates foreign exchange transactions are 
recorded and the date they are consummated.  The Company's exposure to foreign 
currency movements is somewhat mitigated through naturally offsetting currency 
positions.  Remaining exposure is partially reduced through the purchase of 
foreign exchange contracts.  At April 28, 1995, the Company had foreign 
exchange contracts for various foreign currencies totaling $6.3 million.


Note 12. CONTINGENCIES

The Company is subject to various pending and threatened legal actions that 
arise in the normal course of business.  In the opinion of management, 
liabilities arising from these claims, if any, will not have a material effect 
on the Company.
                       

Report of Ernst & Young LLP, Independent Auditors

Board of Directors and Stockholders
Fluke Corporation
Everett, Washington

We have audited the accompanying consolidated balance sheets of Fluke 
Corporation and subsidiaries as of April 28, 1995 and April 29, 1994 and the
related consolidated statements of income, stockholders' equity and cash
flows for each of the two years in the period ended April 28, 1995, the seven
months ended April 30, 1993, and the year ended September 25, 1992.  These
financial statements are the responsibility of the Company's management.  Our
responsibility is to express an opinion on these financial statements based
on our audits.

We conducted our audits in accordance with generally accepted auditing 
standards.  Those standards require that we plan and perform the audit to 
obtain reasonable assurance about whether the financial statements are free of 
material misstatement.  An audit includes examining, on a test basis, evidence 
supporting the amounts and disclosures in the financial statements. An audit 
also includes assessing the accounting principles used and significant 
estimates made by management, as well as evaluating the overall financial 
statement presentation.  We believe that our audits provide a reasonable basis 
for our opinion.

In our opinion, the consolidated financial statements referred to above 
present fairly, in all material respects, the consolidated financial position 
of Fluke Corporation and subsidiaries at April 28, 1995 and April 29, 1994 and
the consolidated results of their operations and their cash flows for each of 
the two years in the period ended April 28, 1995, the seven months ended April 
30, 1993, and the year ended September 25, 1992 in conformity with generally 
accepted accounting principles. 

As discussed in Note 3 and in Note 6 to the financial statements, in 1993 the 
Company changed its method of applying overhead costs to inventories and its 
method of accounting for income taxes.

/s/ Ernst & Young LLP
Seattle, Washington
June 2, 1995


REPORT OF MANAGEMENT

The management of Fluke Corporation (the Company) is responsible for the 
preparation and integrity of the Company's consolidated financial statements 
and related financial information.  The statements have been prepared in 
conformity with generally accepted accounting principles and include the best 
estimates and judgments of management.

The Company maintains a system of internal control, which is designed to 
safeguard the Company's assets and ensure that transactions are recorded in 
accordance with Company policies.  The Company's internal audit program is an 
important part of this control.

The Audit Committee of the Board of Directors is responsible for reviewing and 
approving the Company's consolidated financial statements, the system of 
internal accounting controls and the selection of independent auditors.  The 
Audit Committee, which is comprised entirely of outside Directors, has 
unrestricted access to both internal and external auditors.

George M. Winn                                  John R. Smith
President,                                      Vice President,
Chief Operating Officer                         Treasurer


<TABLE>
                                                        FINANCIAL SUMMARY
In thousands except shares and per share amounts
<CAPTION>
                                                                For the
                                                                  seven
                                          For the     For the    months     For the     For the     For the
                                       year ended  year ended     ended  year ended  year ended  year ended
                                            April       April     April        Sept.       Sept.       Sept.
                                         28, 1995    29, 1994  30, 1993    25, 1992    27, 1991    28, 1990
<S>                                     <C>         <C>       <C>         <C>         <C>         <C>
Revenues                                 $382,066    $357,904  $132,139    $271,819    $239,651    $233,839
Cost of goods sold                       $185,873    $182,475  $ 72,167    $149,776    $129,095    $123,255
Gross margin                             $196,193    $175,429  $ 59,972    $122,043    $110,556    $110,584
Restructuring                                 ---         ---       ---         ---    $ 10,800         ---
Total operating expenses
  excluding restructuring                $172,008    $158,558  $ 56,657    $101,712    $ 97,264    $ 95,213
Operating income                         $ 24,185    $ 16,871  $  3,315    $ 20,331    $  2,492    $ 15,371
Income before income taxes and
  cumulative effect of changes
  in accounting principles               $ 24,034    $ 14,080  $  3,957    $ 21,186    $  3,441    $ 14,693
Cumulative effect of changes in
 accounting principles                        ---    $    ---  $  3,902         ---         ---         ---
Net income                               $ 14,901    $  8,800  $  6,743    $ 15,204    $  3,205    $ 12,178
Average shares and share 
 equivalents outstanding                7,992,804   8,031,696 7,069,463   7,033,695   6,943,941   7,073,292

Income before cumulative effect of
  changes in accounting principles
  per share                              $   1.86    $   1.10  $   0.40    $   2.16    $   0.46    $   1.72
Cumulative effect of changes in
  accounting principles per share             ---    $    ---  $   0.55         ---         ---         ---
Earnings per share                       $   1.86    $   1.10  $   0.95    $   2.16    $   0.46    $   1.72
Pro forma net income <F1>                $ 14,901    $  8,800  $  4,320    $ 14,938    $  3,156    $ 11,836
Pro forma earnings per share <F1>        $   1.86    $   1.10  $   0.61    $   2.12    $   0.45    $   1.67
Income before cumulative effect
  of changes in accounting principles
  as a percentage of revenues                3.90%       2.46%     2.15%       5.59%       1.34%       5.21%
Net income as a percentage of revenues       3.90%       2.46%     5.10%       5.59%       1.34%       5.21%
Cash dividends declared per share        $   0.56    $   0.52  $   0.26    $   0.48    $   0.40    $   0.32
Total assets                             $275,522    $245,602  $172,087    $175,806    $165,826    $151,892
Total stockholders' equity               $175,280    $157,829  $135,187    $129,464    $116,265    $118,066
Long-term obligations                    $ 21,613    $ 14,712  $     34    $    391    $    154    $     94
Long-term interest expense               $  1,423    $  1,327  $     12    $     31    $     28    $    519

<FN>
<F1>  Pro forma data is presented assuming the change in accounting for inventory (explained 
in Note 3) is applied retroactively.

</TABLE>

<TABLE>
                                  SELECTED QUARTERLY FINANCIAL DATA (UNAUDITED)
(in thousands except per share amounts)
<CAPTION>


                              Gross       Net    Earnings  Dividends
                Revenues     Margin    Income   Per Share  Per Share
<S>            <C>        <C>        <C>      <C>         <C>
Fiscal 1995:
  1st Quarter   $ 86,000   $ 42,822   $ 2,401     $0.30     $0.14
  2nd Quarter     91,569     46,205     3,162      0.40      0.14
  3rd Quarter     99,090     50,894     4,225      0.53      0.14
  4th Quarter    105,407     56,272     5,113      0.63      0.14
  Total         $382,066   $196,193   $14,901     $1.86     $0.56

Fiscal 1994: 
  1st Quarter   $ 84,687   $ 40,755   $ 1,420    $0.18      $0.13
  2nd Quarter     89,554     42,824     1,899     0.24       0.13
  3rd Quarter     87,615     42,509     2,380     0.30       0.13
  4th Quarter     96,048     49,341     3,101     0.38       0.13
  Total         $357,904   $175,429   $ 8,800    $1.10      $0.52

</TABLE>

<TABLE>
                    STOCK PRICE INFORMATION
<CAPTION>
                                1995                         1994 
                        High            Low           High            Low
<S>                  <C>            <C>            <C>            <C>
1st Quarter           32             27 3/4         27 1/2         20 1/4
2nd Quarter           31             28             26 5/8         23 3/4
3rd Quarter           30 3/4         27 1/2         26 3/4         22 3/4
4th Quarter           40 5/8         29 3/8         28 3/8         25

</TABLE>

Fluke Corporation stock is traded on the New York Stock Exchange.  The Company 
moved to the New York Stock Exchange from the American and Pacific Stock 
Exchanges on April 10, 1995.

Quarterly cash dividends of $0.14 per share were paid in 1995 and $0.13 per 
share were paid in 1994 and 1993.  The number of stockholders of record at 
April 28, 1995 was 1,882.

 




	






<TABLE>
Exhibit 21

                                SUBSIDIARIES

The Company owns or controls the common stock (the only class authorized) of the following subsidiaries:
<CAPTION>
                                   Percentage of        State or Country
Name of Corporation                  Ownership          of Incorporation
<S>                                 <C>                <C>
Fluke International Corporation      100  <F1>             Washington
Fluke Deutschland GmbH               100  <F2>                Germany
Fluke Electronics Canada, Inc.       100  <F2>                 Canada
Fluke Foreign Sales Corporation      100  <F2>                   Guam
Fluke Holland B.V.                   100  <F2> <F3>   The Netherlands
Fluke Singapore Pte. Ltd.            100  <F2>              Singapore
K. K. Fluke                          100  <F2>                  Japan
Fluke B.V.                           100  <F2>        The Netherlands
Fluke Europe B.V.                    100  <F4>        The Netherlands
Fluke Osterreich GmbH                100  <F4>                Austria
Fluke Belgium N.V./S.A.              100  <F4>                Belgium
Fluke Danmark A.S.                   100  <F4>                Denmark
Fluke Finland Oy                     100  <F4>                Finland
Fluke France S.A.                    100  <F4>                 France
Fluke Italia S.r.l.                  100  <F4>                  Italy
Fluke Norge A/S                      100  <F4>                 Norway
Fluke Iberica S.L.                   100  <F4>                  Spain
Fluke Sverige AB                     100  <F4>                 Sweden
Fluke Switzerland AG                 100  <F4>            Switzerland
Fluke U.K. Ltd.                      100  <F4>         United Kingdom
Fluke Holding B.V.                   100  <F4>        The Netherlands
Fluke Industrial B.V.                100  <F5>        The Netherlands
Fluke Nederland B.V.                 100  <F5>        The Netherlands

<FN>
<F1>  Owned by Fluke Corporation
<F2>  Owned by Fluke International Corporation
<F3>  Not active but remains incorporated
<F4>  Owned by Fluke B.V.
<F5>  Owned by Fluke Holding B.V.

</TABLE>

The accounts of these subsidiaries are included in the accompanying
consolidated financial statements.





Exhibit 23.1

Consent of Ernst & Young LLP, Independent Auditors

We consent to the incorporation by reference in this Annual Report (Form 10-K)
of Fluke Corporation of our report dated June 2, 1995, included in the 1995
Annual Report to Shareholders of Fluke Corporation.

Our audit also included the financial statement schedule of Fluke Corporation
listed in Item 14(a).  This schedule is the responsibility of the Company's
management.  Our responsibility is to express an opinion based on our audits.
In our opinion, the financial statement schedule referred to above, when
considered in relation to the basic financial statements taken as a whole,
presents fairly in all material respects the information set forth therin.

We also consent to the incorporation by reference in the Registration 
Statements, (Form S-8 No. 33-20968) pertaining to the Company's Stock
Purchase Plan, (Form S-8 No. 2-81389) pertaining to the Company's 1988 Stock
Option Plan, (Form S-8 No. 33-38507) pertaining to the Company's 1990 Stock
Incentive Plan, and (Form S-8 No. 33-38506) pertaining to the Company's Stock
Option Plan for Outside Directors of our report dated June 2, 1995, with
respect to the consolidated financial statements incorporated herein by
reference and our report included in the preceding paragraph with respect to
the financial statement schedule included in this Annual Report (Form 10-K)
of Fluke Corporation.

Seattle, Washington
July 27, 1995



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
Consolidated Balance Sheet and Income Statement and is qualified in its
entirety by reference to such financial statements.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          APR-28-1995<F1>
<PERIOD-START>                             MAY-01-1994
<PERIOD-END>                               APR-28-1995
<CASH>                                          28,880
<SECURITIES>                                         0
<RECEIVABLES>                                   78,363
<ALLOWANCES>                                     1,141
<INVENTORY>                                     53,908
<CURRENT-ASSETS>                               182,725
<PP&E>                                         159,480
<DEPRECIATION>                                  97,611
<TOTAL-ASSETS>                                 275,522
<CURRENT-LIABILITIES>                           59,350
<BONDS>                                              0
<COMMON>                                         1,975
                                0
                                          0
<OTHER-SE>                                     173,305
<TOTAL-LIABILITY-AND-EQUITY>                   275,522
<SALES>                                        382,066
<TOTAL-REVENUES>                               382,066
<CGS>                                          185,873
<TOTAL-COSTS>                                  172,008
<OTHER-EXPENSES>                               (1,284)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,435
<INCOME-PRETAX>                                 24,034
<INCOME-TAX>                                     9,133
<INCOME-CONTINUING>                             14,901
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    14,901
<EPS-PRIMARY>                                     1.86
<EPS-DILUTED>                                     1.86
<FN>
<F1>All amounts are in thousands except per share amounts.
</FN>
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission